Other disorders of fluid, electrolyte and acid-base balance

E4_FLUIDELECTRO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87 Cause of death: ICD-10 — E87 2 out of 7 registries used, show all original rules.	13671
4. Check minimum number of events None	13671
5. Include endpoints E4_HYPEROSMHNAT E4_HYPOOSMNAT E4_ACIDOSIS E4_ALKALOSIS E4_MIXACIDBASE E4_HYPERKALAEMIA E4_HYPOKALAEMIA E4_FLUIDOVER E4_FLUIDELECTRONAS	13897
6. Filter based on genotype QC (FinnGen only)	13897

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Aliae perturbationes aequilibrii humoralis, electrolytici et acido-alkalici

NAME	E4_FLUIDELECTRO
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_HYPEROSMHNAT\|E4_HYPOOSMNAT\|E4_ACIDOSIS\|E4_ALKALOSIS\|E4_MIXACIDBASE\|E4_HYPERKALAEMIA\|E4_HYPOKALAEMIA\|E4_FLUIDOVER\|E4_FLUIDELECTRONAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E87
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E87
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of fluid, electrolyte and acid-base balance based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	135674	82514	52202
Only index persons	114174	70187	43987
Unadjusted period prevalence (%)
Whole population	2.01	2.36	1.46
Only index persons	2.23	2.58	1.68
Median age at first event (years)
Whole population	72.18	75.73	66.59
Only index persons	72.02	75.45	66.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13897	7676	6221
Unadjusted period prevalence (%)	2.67	2.62	2.74
Median age at first event (years)	68.82	68.97	68.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12313: Matched controls
119428

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.8

323.0

1162

2108

A28

ICPC

Limited function/disability NOS

2.8

323.0

2823

11478

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.6

323.0

1663

4979

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

323.0

6637

36038

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

323.0

2049

6603

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

477.8

323.0

430

A02BC02

ATC

pantoprazole; systemic

2.2

323.0

8374

58494

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.8

323.0

2050

5947

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.7

323.0

1741

2852

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.0

323.0

2390

8848

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

323.0

3584

10994

I10

ICD-10 Finland

Essential (primary) hypertension

2.8

323.0

8582

53674

I50.9

ICD-10 Finland

Heart failure, unspecified

3.3

323.0

2938

10265

C03CA01

ATC

furosemide; systemic

3.5

323.0

6019

25508

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

323.0

3591

16670

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.0

323.0

2645

9847

E87.2

ICD-10 Finland

Acidosis

2999.8

323.0

609

C08CA01

ATC

amlodipine; oral

2.7

323.0

5835

29920

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

7.6

323.0

1076

1476

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

323.0

4314

19157

N05AH04

ATC

quetiapine; oral

3.1

323.0

2496

9060

R53

ICD-10 Finland

Malaise and fatigue

3.4

323.0

3773

13859

R11

ICD-10 Finland

Nausea and vomiting

4.4

323.0

1685

4109

AA1AD

NOMESCO Finland

CT of head and brain

3.4

323.0

4489

17226

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

486.8

323.0

6414

264

205

Kela drug reimbursment

Chronic hypertension

2.3

323.0

4611

24599

E87.5

ICD-10 Finland

Hyperkalaemia

174.4

323.0

1877

123

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

323.0

3157

14159

E87.6

ICD-10 Finland

Hypokalaemia

188.9

323.0

4109

316

C03DA01

ATC

spironolactone; oral

4.4

323.0

2639

6917

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.9

323.0

3149

9604

N05BA04

ATC

oxazepam; oral

2.4

323.0

3671

18062

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

323.0

2202

6937

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

323.0

4462

21949

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

323.0

2287

8020

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

323.0

4656

24634

N06AX11

ATC

mirtazapine; oral

2.3

323.0

4448

23438

E86

ICD-10 Finland

Volume depletion

91.0

323.0

790

N17.9

ICD-10 Finland

Acute renal failure, unspecified

8.9

323.0

1301

1569

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.7

323.0

1331

3004

C07AB07

ATC

bisoprolol; oral

2.5

323.0

7068

41909

A10AE04

ATC

insulin glargine; parenteral

3.5

306.8

1593

4813

N05CF01

ATC

zopiclone; oral

2.1

306.7

4793

27405

A06AD11

ATC

lactulose; oral

2.6

305.9

2661

11381

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.0

302.8

1330

3484

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

295.1

3879

20441

N02AA05

ATC

oxycodone; systemic

2.6

291.7

2517

10678

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

289.3

2366

9726

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

283.0

2250

9082

L28

ICPC

Limited function/disability (L)

2.5

275.4

2562

11289

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.3

274.9

1590

5189

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

274.0

4786

28294

SPAT1254

SPAT

Administration of medicine

2.6

271.7

2403

10287

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

269.8

3293

16623

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

265.7

1646

5633

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.8

265.6

649

850

R06.0

ICD-10 Finland

Dyspnoea

2.2

264.3

3489

18232

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

16.8

264.3

436

260

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.2

254.1

527

522

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

251.4

1693

6114

N02BE01

ATC

paracetamol; systemic, rectal

2.3

250.7

10496

85699

SPAT1262

SPAT

Handing over of treatment supplies

2.4

247.7

2642

12412

WX892

NOMESCO Finland

Monitored bed care

3.4

247.3

1315

4010

I50.0

ICD-10 Finland

Congestive heart failure

3.2

243.3

1463

4883

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

241.8

2526

11725

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

239.8

2444

11196

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.2

236.4

3069

15772

N03AG01

ATC

valproic acid; systemic, rectal

3.9

236.0

1065

2831

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.2

234.0

777

1521

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

230.6

2199

9709

N05BA01

ATC

diazepam; systemic, rectal

2.5

230.0

2103

9078

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

229.5

1279

4030

C08CA13

ATC

lercanidipine; oral

2.5

227.0

2069

8908

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

226.0

2888

14688

N06AB04

ATC

citalopram; systemic

2.2

224.7

2936

15073

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.8

223.6

1054

2904

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.3

223.1

724

1379

C09AA05

ATC

ramipril; oral

2.0

223.1

3493

19360

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.0

220.6

976

2545

B01AC04

ATC

clopidogrel; oral

2.5

220.4

2098

9233

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.9

218.7

974

2554

C02AC05

ATC

moxonidine; oral

4.2

216.0

883

2140

H02AB09

ATC

hydrocortisone; systemic

7.5

214.3

535

721

N03AX16

ATC

pregabalin; oral

2.1

214.2

3096

16549

N07BB01

ATC

disulfiram; oral

4.8

212.8

765

1630

N05AH03

ATC

olanzapine; systemic

3.9

210.9

943

2478

P15

ICPC

Chronic alcohol abuse

6.6

209.9

572

874

A04

ICPC

Weakness/tiredness general

2.5

207.8

1901

8167

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.2

206.3

1190

3830

C10AA01

ATC

simvastatin; oral

1.8

206.0

5491

36668

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.3

205.4

520

715

N30.0

ICD-10 Finland

Acute cystitis

2.4

204.7

2023

9042

TK800

NOMESCO Finland

Hemodialysis

7.3

202.6

514

709

J01DB01

ATC

cefalexin; oral

1.9

202.2

9572

77026

T90

ICPC

Diabetes non-insulin dependent

2.1

201.9

3022

16320

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

201.1

4152

25341

J01MA02

ATC

ciprofloxacin; systemic

1.8

199.8

5016

32722

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

12.7

199.0

368

288

F10.24

ICD-10 Finland

Alcohol depence active use

10.8

198.6

398

368

N18.8

ICD-10 Finland

Other chronic renal failure

5.6

196.8

611

1102

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

11.3

194.9

381

335

A10BA02

ATC

metformin; oral

1.9

194.6

3630

21293

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

11.6

194.3

376

324

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.0

193.7

1218

4159

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.2

193.3

1140

3721

R42

ICD-10 Finland

Dizziness and giddiness

2.0

192.8

2986

16301

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

192.6

2211

10600

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

192.5

968

2801

A46

ICD-10 Finland

Erysipelas

2.3

192.4

2086

9733

J01MA12

ATC

levofloxacin; systemic

2.1

192.0

2584

13306

N02AX02

ATC

tramadol; systemic, rectal

1.8

191.8

5271

35260

R55

ICD-10 Finland

Syncope and collapse

2.5

191.2

1699

7158

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

190.8

1194

4062

V03AE01

ATC

polystyrene sulfonate; oral

10.8

190.6

382

353

N05CD07

ATC

temazepam; oral

2.3

190.6

2105

9905

TKC20

NOMESCO Finland

Catheterisation of bladder

3.0

188.8

1232

4308

N19

ICD-10 Finland

Unspecified kidney failure

4.6

188.1

697

1529

H02AB06

ATC

prednisolone; systemic

1.8

187.8

5719

39431

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.7

187.1

572

1012

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

185.7

3154

17801

C07AB02

ATC

metoprolol; systemic

2.0

185.3

3050

17006

F10.20

ICD-10 Finland

Alcohol dependence currently independent

7.1

184.9

478

677

R60.0

ICD-10 Finland

Localized oedema

2.5

184.5

1711

7364

N03AX14

ATC

levetiracetam; systemic

5.8

184.1

556

969

A12BA01

ATC

potassium chloride; oral

3.3

183.2

1023

3205

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

182.9

1437

5637

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

148.5

182.7

196

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

180.7

2717

14597

C01DA14

ATC

isosorbide mononitrate; oral

2.1

179.8

2295

11506

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.5

179.1

492

758

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

177.7

2498

13041

N05AA02

ATC

levomepromazine; systemic

3.9

177.3

783

2027

UJF32

NOMESCO Finland

Coloscopy

1.9

177.0

3376

19826

M04AA01

ATC

allopurinol; systemic

2.3

176.7

1935

9036

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

176.7

3359

19702

A11CC03

ATC

alfacalcidol; systemic

6.6

176.4

480

730

N05AX08

ATC

risperidone; systemic

2.7

175.8

1306

4947

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

174.8

3335

19570

C09AA02

ATC

enalapril; systemic

2.0

174.1

2878

16012

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.6

173.8

840

2348

R50.9

ICD-10 Finland

Fever, unspecified

2.3

172.3

1871

8690

R41.0

ICD-10 Finland

Disorientation, unspecified

4.3

171.9

683

1603

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.2

170.3

400

489

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

170.0

2387

12426

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

169.2

2321

11964

R33

ICD-10 Finland

Retention of urine

2.7

166.8

1280

4936

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.5

165.4

1506

6388

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

14.3

164.9

289

200

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

6.6

163.8

444

671

SPAT1263

SPAT

Sampling

1.7

163.0

5053

34504

A10AE05

ATC

insulin detemir; parenteral

3.5

162.8

829

2413

ZX120

NOMESCO Finland

Intravenous

2.6

159.9

1354

5516

C03AA03

ATC

hydrochlorothiazide; oral

2.4

159.1

1525

6638

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

154.2

697

1837

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.4

152.6

422

655

E83.51

ICD-10 Finland

Hypocalcemia

81.6

152.5

174

SPAT1229

SPAT

Assessment of need for aid

2.5

152.4

1295

5279

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

151.7

3574

22302

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

151.6

993

3460

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

151.6

1474

6452

C10AA05

ATC

atorvastatin; oral

1.7

150.2

4352

28918

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

150.2

1210

4784

S97

ICPC

Chronic ulcer skin

3.1

149.8

906

2991

SPAT1216

SPAT

Assessment of functional ability

2.0

148.7

2226

11814

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.7

148.2

397

590

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

147.5

1490

6643

N06AX16

ATC

venlafaxine; oral

2.3

147.3

1526

6888

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.7

147.3

393

581

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

146.7

2667

15216

F05.9

ICD-10 Finland

Delirium, unspecified

5.5

146.5

457

826

SPAT1301

SPAT

No procedures

1.7

142.8

3960

25873

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.9

142.7

640

1673

S06.0

ICD-10 Finland

Concussion

2.4

142.7

1376

5987

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

9.8

142.3

299

302

AN1

Coronary angiography

2.3

139.8

1509

6935

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

139.8

1114

4371

N03AF02

ATC

oxcarbazepine; oral

4.4

139.4

543

1246

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

137.0

1068

4135

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

134.9

1487

6893

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

134.7

918

3274

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

134.2

1212

5085

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

133.9

819

2719

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

133.6

3116

19228

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

133.6

2838

16993

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

133.6

2191

11984

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.7

133.3

356

527

N03AX09

ATC

lamotrigine; oral

3.9

133.0

586

1507

J01FF01

ATC

clindamycin; systemic

1.8

131.5

3143

19526

A10BH01

ATC

sitagliptin; oral

2.4

131.1

1268

5512

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

130.9

869

3045

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.1

130.8

770

2487

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.0

130.8

309

381

B01AA03

ATC

warfarin; systemic

1.8

130.0

2846

17184

N06AB10

ATC

escitalopram; oral

2.0

129.5

2053

11073

C08CA02

ATC

felodipine; oral

2.2

129.2

1423

6584

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

128.6

1310

5840

A02BC01

ATC

omeprazole; systemic

1.7

128.3

3444

22127

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

5.3

128.1

412

771

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

11.0

127.8

253

228

A12AA04

ATC

calcium carbonate; oral

7.0

126.7

329

468

N06AX21

ATC

duloxetine; oral

2.3

126.6

1266

5588

N17.8

ICD-10 Finland

Other acute renal failure

8.6

126.4

287

332

WX872

NOMESCO Finland

Intensive care

3.1

126.3

738

2371

R03BB04

ATC

tiotropium bromide; inhalant

2.2

125.7

1413

6594

T89

ICPC

Diabetes insulin dependent

4.2

125.2

510

1221

G72.8

ICD-10 Finland

Other specified myopathies

6.2

125.0

354

567

B03XA02

ATC

darbepoetin alfa; parenteral

5.7

124.9

379

662

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

124.6

3618

23731

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

124.5

2153

11971

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

124.5

1479

7075

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.5

124.5

620

1766

C09CA01

ATC

losartan; oral

1.7

124.5

2997

18604

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

124.4

1029

4110

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

123.7

621

1780

WX882

NOMESCO Finland

High dependency care

4.2

123.0

501

1199

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

122.6

756

2520

B01AB05

ATC

enoxaparin; parenteral

1.7

121.3

3672

24330

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

121.1

4272

29490

JN4AD

NOMESCO Finland

Body CT examination

2.4

120.0

1092

4588

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

119.9

948

3689

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.9

119.7

286

359

R51.80

ICD-10 Finland

Headache

2.1

119.2

1547

7677

N03AF01

ATC

carbamazepine; oral, rectal

2.8

119.0

813

2895

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

119.0

931

3598

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.8

117.9

537

1420

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.2

117.8

388

746

P16

ICPC

Acute alcohol abuse

7.1

117.6

300

416

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.1

117.6

491

1202

SPAT1234

SPAT

Support of social functional capacity

2.8

117.5

838

3066

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

117.5

2115

11900

R4110

NOMESCO Finland

Physiotherapy

1.7

116.9

3054

19359

J01EA01

ATC

trimethoprim; systemic

1.7

115.4

3143

20152

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.2

115.0

377

721

E0000UV

ATC

1.6

114.7

4355

30522

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

114.5

1254

5768

N03AX12

ATC

gabapentin; oral

1.9

113.0

1821

9828

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

112.9

1050

4456

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

112.9

2254

13117

N06AB06

ATC

sertraline; oral

2.3

112.9

1180

5306

N05AF03

ATC

chlorprothixene; systemic

4.2

111.7

447

1051

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

110.4

1844

10078

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.6

110.2

249

286

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

110.1

3612

24313

W19

ICD-10 Finland

Unspecified fall

2.2

110.0

1257

5887

A10BB12

ATC

glimepiride; oral

2.3

109.8

1077

4692

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.7

109.7

506

1351

K92.1

ICD-10 Finland

Melaena

2.8

109.7

790

2903

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

108.8

472

1195

N05BA02

ATC

chlordiazepoxide; systemic

4.1

108.5

448

1085

WW500

NOMESCO Finland

Blood transfusion

3.1

108.3

636

2044

JN4BD

NOMESCO Finland

Extensive body CT

2.0

107.9

1490

7565

A02BC05

ATC

esomeprazole; systemic

1.6

107.8

4562

32698

S01.0

ICD-10 Finland

Open wound of scalp

2.4

107.5

1036

4474

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

107.2

802

3015

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

107.1

2946

18868

A10BH05

ATC

linagliptin; oral

2.9

107.1

709

2471

K92.0

ICD-10 Finland

Haematemesis

4.0

106.8

457

1143

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.0

106.7

460

1158

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

106.6

776

2870

2768A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]

+∞

106.2

103

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

12.7

105.6

194

150

Z51.5

ICD-10 Finland

Palliative care

2.5

104.4

919

3783

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

11.0

104.2

205

183

N30.9

ICD-10 Finland

Cystitis, unspecified

2.6

104.2

813

3133

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

104.1

594

1872

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.6

103.8

508

1424

127

Kela drug reimbursment

Transplant complication

6.8

102.9

270

390

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.2

102.4

192

155

Z94.0

ICD-10 Finland

Kidney transplant status

8.7

102.3

230

262

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.3

102.1

549

1656

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

101.6

2380

14507

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

100.7

962

4130

J01CA08

ATC

pivmecillinam; oral

1.5

100.6

4362

31288

C07AA05

ATC

propranolol; systemic

1.8

100.0

2063

12078

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

6.5

98.8

269

409

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

98.3

4216

30122

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.0

98.3

231

283

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.8

97.3

193

175

WX730

NOMESCO Finland

Conventional respirator

5.1

97.2

322

623

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

97.2

1247

6126

N06AA09

ATC

amitriptyline; systemic

2.1

96.9

1289

6429

M79.6

ICD-10 Finland

Pain in limb

1.6

96.5

3815

26705

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

95.8

1138

5407

I25.2

ICD-10 Finland

Old myocardial infarction

2.4

95.1

901

3846

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

95.0

677

2468

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.0

95.0

407

1019

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

94.8

1803

10258

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.8

94.7

427

1118

SPAT1167

SPAT

Insertion of urinary catheter

3.2

94.5

544

1722

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.3

94.4

264

416

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.3

94.3

508

1534

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

67.1

94.2

110

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.6

93.7

767

3029

C07AG02

ATC

carvedilol; oral

2.4

93.3

857

3602

I95.1

ICD-10 Finland

Orthostatic hypotension

3.1

92.8

540

1724

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

92.7

651

2350

M10.9

ICD-10 Finland

Gout, unspecified

2.4

92.2

852

3590

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

303.3

91.8

K70.1

ICD-10 Finland

Alcoholic hepatitis

10.6

91.7

184

171

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

91.4

862

3672

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.5

90.9

340

748

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

90.6

1942

11470

UKC02

NOMESCO Finland

Cystoscopy

1.7

89.5

2017

12096

E87.7

ICD-10 Finland

Fluid overload

437.5

89.2

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.5

89.1

772

3143

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.6

88.7

429

1190

E83.50

ICD-10 Finland

Hypercalcemia

12.5

88.7

164

129

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

87.9

528

1721

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

87.1

1736

10006

SPAT1240

SPAT

Therapeutic discussion

2.2

86.8

986

4584

N06AB03

ATC

fluoxetine; oral

1.9

86.8

1398

7487

I50.1

ICD-10 Finland

Left ventricular failure

2.6

86.8

706

2779

207

Kela drug reimbursment

Chronic arrhythmias

1.8

86.7

1892

11219

L04AA06

ATC

mycophenolic acid; systemic

5.4

86.7

272

495

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

86.2

665

2538

137

Kela drug reimbursment

Uraemia requiring dialysis

8.7

86.1

193

219

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

86.1

502

1604

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

86.0

831

3579

WX002

NOMESCO Finland

Sedation and analgesia

1.7

85.9

2284

14352

R02

ICPC

Shortness of breath/dyspnoea

1.9

85.8

1407

7580

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

85.3

918

4160

Z71.8

ICD-10 Finland

Other specified counselling

1.6

85.2

2378

15141

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

85.1

5161

39385

SPAT1260

SPAT

Consultation of another employee

1.7

84.9

2074

12715

R03AC02

ATC

salbutamol; inhalant

1.5

84.8

5469

42251

J01MA14

ATC

moxifloxacin; systemic

2.1

84.5

1082

5294

R63.1

ICD-10 Finland

Polydipsia

23.6

84.4

123

M54.5

ICD-10 Finland

Low back pain

1.5

84.4

3332

23149

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.6

84.3

178

182

I50

ICD-10 Finland

Heart failure

3.0

84.0

518

1720

WZC30

NOMESCO Finland

Teaching

1.8

83.4

1493

8294

SPAT1255

SPAT

Intravenous administration of medicine

2.3

83.2

864

3849

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

82.9

3335

23246

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.2

82.7

905

4132

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

82.7

615

2298

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

82.5

1567

8875

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

82.2

655

2546

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.8

82.1

243

412

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.3

82.0

324

753

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.6

81.7

198

255

WX110

NOMESCO Finland

Local anesthesy

1.4

81.4

7059

57612

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.0

81.2

502

1668

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.0

80.8

339

833

N05AX12

ATC

aripiprazole; systemic

3.7

80.8

378

1021

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.6

80.7

388

1071

R18

ICD-10 Finland

Ascites

4.1

80.3

328

786

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

80.1

511

1734

N18.0

ICD-10 Finland

End-stage renal disease

6.1

80.0

227

365

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

80.0

1325

7155

XF404

NOMESCO Finland

Ambulatory ECG

2.0

80.0

1105

5573

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

79.9

473

1527

H03AA01

ATC

levothyroxine sodium; systemic

1.6

79.8

2531

16626

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

79.6

4808

36497

P29

ICPC

Psychological sympt/compl other

2.8

79.5

536

1885

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

79.3

921

4317

N05BA12

ATC

alprazolam; oral

2.0

78.9

1173

6084

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

78.8

1235

6530

I20.09

ICD-10 Finland

Unstable angina

2.4

78.8

701

2890

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

78.8

4280

31774

K08.3

ICD-10 Finland

Retained dental root

2.2

78.5

852

3875

A29

ICPC

General symptom/complaint other

1.9

78.4

1354

7415

B05DA

ATC

Isotonic solutions

9.8

78.4

164

165

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

78.4

1612

9356

S18

ICPC

Laceration/cut

1.5

78.3

4659

35217

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

78.2

1806

10862

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

77.8

845

3842

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

8.0

77.8

183

225

B01AF02

ATC

apixaban; oral

1.9

77.7

1230

6530

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

77.3

546

1977

N06AX03

ATC

mianserin; oral

2.5

76.9

656

2644

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

9.3

76.7

165

175

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

22.6

76.6

113

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.2

76.4

307

725

P01AB01

ATC

metronidazole; oral, rectal

1.5

76.3

4047

29837

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

76.3

3412

24266

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.7

75.7

345

911

B01AB10

ATC

tinzaparin; parenteral

2.2

75.7

847

3904

A02BC03

ATC

lansoprazole; oral

1.5

75.6

3319

23495

J01DA01

ATC

[U] cefalexin; systemic

1.4

75.5

6884

56311

Z49.2

ICD-10 Finland

Other dialysis

9.6

75.1

158

161

N03AE01

ATC

clonazepam; systemic

2.3

75.0

729

3142

I95.9

ICD-10 Finland

Hypotension, unspecified

4.8

74.9

261

534

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.7

74.9

224

385

C09BA02

ATC

enalapril and diuretics; systemic

2.0

74.9

1098

5660

A10AA01

ATC

3.9

74.4

327

837

K59.0

ICD-10 Finland

Constipation

2.3

74.3

746

3267

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

74.1

1135

5947

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

73.9

919

4433

N05AD01

ATC

haloperidol; systemic

2.9

73.2

487

1698

E87.3

ICD-10 Finland

Alkalosis

+∞

73.2

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.6

72.9

576

2226

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.4

72.8

278

625

E000001

ATC

1.6

72.8

2177

14042

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

72.7

847

3971

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.8

72.6

161

180

A01

ICPC

Pain general/multiple sites

2.1

72.6

910

4402

N03AX18

ATC

lacosamide; systemic

9.7

72.5

152

154

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

72.4

1535

8979

N06AA12

ATC

doxepin; systemic

2.3

72.2

718

3128

SPAT1125

SPAT

Stoma care and guidance

4.0

71.7

301

740

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.9

71.7

314

802

H3603, E103

ICD-10 Finland

9.0

71.6

157

172

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

71.3

516

1894

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

71.2

652

2727

N05BE01

ATC

buspirone; oral

3.2

70.9

389

1190

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

70.9

3667

26799

EBA00

NOMESCO Finland

Extraction of tooth

1.5

70.6

3253

23198

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.8

70.6

493

1772

H04AA01

ATC

glucagon; nasal, parenteral

4.6

70.6

259

560

SPAT1252

SPAT

Overall medication plan or its review

2.1

70.2

914

4489

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

69.7

640

2680

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.4

69.4

645

2716

N05AH02

ATC

clozapine; systemic

4.6

69.2

251

536

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

69.2

915

4521

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.0

68.9

177

249

C09CA03

ATC

valsartan; oral

1.9

68.7

1059

5553

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

12.6

68.6

126

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.5

68.5

341

969

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

68.4

2678

18403

C08CA05

ATC

nifedipine; systemic

2.1

68.2

865

4203

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

12.6

68.2

125

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

67.8

1562

9355

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

67.3

1249

6990

A10AA02

ATC

2.9

67.3

446

1550

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.7

67.2

177

258

Z72.1

ICD-10 Finland

Alcohol use

5.3

67.0

213

394

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.9

67.0

426

1442

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

66.8

317

866

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.0

66.7

283

703

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

66.6

766

3568

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

66.4

801

3806

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.4

66.3

338

978

E26.0

ICD-10 Finland

Primary hyperaldosteronism

9.3

66.0

141

148

C09CA06

ATC

candesartan; oral

1.6

66.0

2254

14983

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

+∞

65.9

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.6

65.9

314

861

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

65.8

963

4949

V03AA01

ATC

4.1

65.4

267

640

N05AB03

ATC

perphenazine; systemic, rectal

2.8

65.1

453

1625

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

65.1

750

3495

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.0

65.0

276

686

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

65.0

1127

6157

N05CF02

ATC

zolpidem; oral

1.6

64.9

1793

11287

M05BA04

ATC

alendronic acid; oral

1.8

64.6

1183

6583

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.9

64.4

278

701

B05DB

ATC

Hypertonic solutions

9.6

64.4

135

137

A41.8

ICD-10 Finland

Other specified sepsis

4.0

64.1

270

666

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

63.9

1300

7487

TK810

NOMESCO Finland

Hemofiltration

8.9

63.8

140

154

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

63.8

684

3086

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

15.1

63.7

108

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.2

63.5

251

584

P01

ICPC

Feeling anxious/nervous/tense

2.1

63.5

741

3471

ZXA00

NOMESCO Finland

Right side

1.5

63.4

3071

22033

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.0

63.4

395

1320

H02AA02

ATC

fludrocortisone; oral

6.0

63.2

182

299

N04AA02

ATC

biperiden; systemic

3.6

63.1

301

826

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.8

62.9

124

112

SPAT1310

SPAT

Counselling related to known health issue

1.4

62.9

3380

24753

183

Kela drug reimbursment

Lamotrigin and topiramate

6.8

62.9

164

236

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

10.0

62.9

129

126

A02BA02

ATC

ranitidine; systemic

1.5

62.4

2304

15572

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

62.4

1164

6518

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

62.3

518

2058

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

62.1

1092

5994

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

61.9

1123

6228

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

61.4

1166

6563

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.6

61.1

221

471

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

61.1

898

4621

H02AB04

ATC

methylprednisolone; systemic

1.6

61.0

1601

9925

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.1

60.9

247

589

78891

ICD-8 Finland

Other general symptoms, Hypokaliaemia

+∞

60.8

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.3

60.8

612

2678

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

19.1

60.6

V03AE02

ATC

sevelamer; oral

11.2

60.5

117

102

SPAT1104

SPAT

Monitoring of emergency patient

2.0

60.2

795

3923

F34.1

ICD-10 Finland

Dysthymia

3.0

59.9

370

1229

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

59.9

2017

13325

K70.0

ICD-10 Finland

Alcoholic fatty liver

7.1

59.8

152

211

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

59.8

809

4030

L17

ICPC

Foot/toe symptom/complaint

1.5

59.8

2585

18070

P99

ICPC

Psychological disorders other

3.5

59.8

297

843

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.6

59.7

283

773

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.2

59.6

137

163

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.1

59.5

349

1120

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

59.3

768

3757

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

59.2

1834

11864

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.4

59.2

308

906

196

Kela drug reimbursment

Paricalcitol and cinacalcet

12.4

59.1

109

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.4

58.8

183

331

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

58.5

796

3971

SPAT1265

SPAT

Breathalyser

6.2

58.5

164

261

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.2

58.4

232

543

SPAT1097

SPAT

Recording of ECG

1.6

58.3

1694

10775

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

57.9

476

1879

ZXA05

NOMESCO Finland

Left side

1.5

57.9

2855

20491

R4190

NOMESCO Finland

Nutritional therapy

2.9

57.8

372

1269

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

57.7

458

1773

NHQ40

NOMESCO Finland

Amputation of toe

3.7

57.6

261

687

J96.0

ICD-10 Finland

Acute respiratory failure

4.3

57.5

225

519

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.2

57.5

226

524

P72

ICPC

Schizophrenia

4.0

57.4

239

584

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

57.3

786

3934

Angiography of the heart and coronary arteries

2.0

57.3

758

3739

K77

ICPC

Heart failure

3.2

57.3

321

997

SPAT1211

SPAT

Application of soft bandage

1.8

57.2

1036

5734

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.7

57.2

261

691

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

9.4

57.0

121

126

SPAT1172

SPAT

Guidance concerning hydration

2.9

56.6

362

1231

C01AA05

ATC

digoxin; systemic

1.8

56.6

1157

6657

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

56.5

625

2857

I20.00

ICD-10 Finland

Unstable angina

2.7

56.3

399

1446

A10AE06

ATC

insulin degludec; parenteral

3.3

56.3

302

909

R04.0

ICD-10 Finland

Epistaxis

1.9

56.2

853

4437

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

56.0

513

2144

E23.00

ICD-10 Finland

Panhypopituitarism

11.8

55.7

105

K07

ICPC

Swollen ankles/oedema

2.3

55.7

570

2515

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

55.7

1704

10976

C09DA01

ATC

losartan and diuretics; oral

1.7

55.6

1185

6907

R07.3

ICD-10 Finland

Other chest pain

1.8

55.4

975

5341

A07AA09

ATC

vancomycin; oral

4.3

55.3

213

484

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

55.3

850

4440

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.2

55.2

219

512

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.4

55.1

125

146

R31

ICD-10 Finland

Unspecified haematuria

1.7

55.1

1147

6636

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

55.0

328

1064

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

54.8

651

3071

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

54.8

217

507

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

54.8

368

1290

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

54.7

662

3148

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

14.9

54.7

E87

ICD-10 Finland

Other disorders of fluid, electrolyte and acid-base balance

57.6

54.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

54.6

4556

35880

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.7

54.6

162

277

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

54.5

969

5326

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

8.6

54.4

121

137

X58

ICD-10 Finland

Exposure to other specified factors

1.7

54.3

1296

7806

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.5

54.3

457

1826

R06AE07

ATC

cetirizine; oral

1.4

54.2

4236

32986

P03

ICPC

Feeling depressed

2.1

54.1

686

3323

F61.0

ICD-10 Finland

Mixed personality disorders

4.6

54.1

195

415

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

54.1

313

995

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

54.1

1355

8273

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.7

54.1

395

1459

D07AC01

ATC

betamethasone; topical

1.4

54.0

3521

26567

A07AA02

ATC

nystatin; oral

2.0

54.0

772

3927

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

53.7

860

4560

J01CF05

ATC

flucloxacillin; systemic

2.6

53.5

424

1640

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

53.5

689

3361

A08

ICPC

Swelling

2.3

53.3

520

2242

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

53.3

671

3243

S72.0

ICD-10 Finland

Fracture of neck of femur

2.2

53.2

575

2599

M48.0

ICD-10 Finland

Spinal stenosis

1.6

53.2

1402

8679

Y94.0

ICD-10 Finland

Accident at home

3.4

53.2

276

811

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.4

53.1

477

1974

N05AN01

ATC

lithium; oral

3.3

52.9

281

840

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.5

52.7

446

1786

K56.7

ICD-10 Finland

Ileus, unspecified

3.5

52.6

258

725

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.5

52.6

431

1699

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

10.1

52.4

107

104

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.1

52.4

307

984

G41.9

ICD-10 Finland

Status epilepticus, unspecified

7.3

52.3

129

172

XF402

NOMESCO Finland

ECG with work load test

1.7

51.7

1113

6499

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

9.6

51.6

108

110

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

51.6

1149

6776

M05BX04

ATC

denosumab; parenteral

2.1

51.5

647

3121

H3600, E103

ICD-10 Finland

6.6

51.4

137

204

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.2

51.4

568

2595

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

51.2

2058

14099

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

51.2

336

1162

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

51.2

503

2176

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

51.2

481

2036

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.1

51.2

168

324

R40.2

ICD-10 Finland

Coma, unspecified

5.2

51.1

165

312

N05AB01

ATC

dixyrazine; systemic

4.1

51.1

208

499

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.3

51.0

161

297

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

7.3

50.9

126

169

105

Kela drug reimbursment

Adrenal cortical hypofunction

17.0

50.9

D07AA02

ATC

hydrocortisone; topical

1.6

50.8

1318

8115

P20

ICPC

Memory disturbance

1.6

50.7

1497

9536

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.9

50.7

322

1091

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

7.2

50.5

126

171

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

50.5

414

1633

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.9

50.4

216

543

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.1

50.3

165

318

WW200

NOMESCO Finland

Immunization

3.0

50.1

303

994

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.7

49.9

358

1308

C03BA11

ATC

indapamide; oral

2.5

49.8

397

1542

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

49.7

431

1752

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.2

49.6

195

453

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

49.4

1710

11317

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

49.4

661

3273

S70.0

ICD-10 Finland

Contusion of hip

2.4

49.3

452

1890

K85

ICPC

Elevated blood pressure

1.5

49.2

1685

11119

C10AA04

ATC

fluvastatin; oral

1.8

49.2

946

5332

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

8.8

49.1

108

120

N17

ICPC

Vertigo/dizziness

1.7

49.1

1190

7190

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.7

49.0

359

1327

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

49.0

563

2616

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.4

49.0

184

409

H02AB07

ATC

prednisone; oral

1.6

49.0

1554

10073

U04

ICPC

Incontinence urine

2.1

48.9

569

2656

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

48.8

448

1873

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

48.8

489

2134

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

48.8

533

2423

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.2

48.7

156

293

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

48.6

625

3043

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

48.6

414

1666

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

48.2

930

5247

ZZA00

NOMESCO Finland

Split skin graft

2.5

48.1

390

1528

A99

ICPC

Disease/condition unspecnature/site

1.8

48.1

867

4783

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

48.1

595

2854

R52.9

ICD-10 Finland

Pain, unspecified

1.8

48.0

842

4602

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.5

48.0

147

262

P76

ICPC

Depressive disorder

2.2

47.9

496

2200

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

47.8

344

1258

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.0

47.8

111

135

N05AF05

ATC

zuclopenthixol; systemic

4.7

47.8

170

358

TK820

NOMESCO Finland

Peritoneal dialysis

9.2

47.7

102

108

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.7

47.6

220

590

N06AX26

ATC

vortioxetine; oral

2.3

47.2

471

2052

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

47.0

257

786

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.3

46.9

180

409

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

46.8

489

2178

U05

ICPC

Urination problems other

2.1

46.8

547

2561

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

8.9

46.8

102

112

A04AA01

ATC

ondansetron; systemic, rectal

1.9

46.7

710

3689

J46

ICD-10 Finland

Status asthmaticus

2.7

46.5

329

1192

S22.3

ICD-10 Finland

Fracture of rib

1.9

46.5

710

3697

JAH00

NOMESCO Finland

Laparotomy

2.6

46.4

357

1356

C08DB01

ATC

diltiazem; oral

1.9

46.4

713

3721

E66.8

ICD-10 Finland

Other obesity

2.4

46.2

410

1684

J01FA06

ATC

roxithromycin; oral

1.3

46.1

4140

32728

SPAT1251

SPAT

Organisation of medication

2.2

45.8

476

2113

E10

ICD-10 Finland

Type 1 diabetes mellitus

4.1

45.7

187

451

H05BX01

ATC

cinacalcet; oral

7.5

45.7

111

145

N05AC02

ATC

thioridazine; oral

3.1

45.6

268

861

K90

ICPC

Stroke/cerebrovascular accident

2.7

45.3

330

1217

K85

ICD-10 Finland

Acute pancreatitis

3.3

45.3

239

712

C10AX09

ATC

ezetimibe; oral

1.8

45.3

898

5103

U07

ICPC

Urine symptom/complaint other

2.0

45.3

650

3305

N05AA01

ATC

chlorpromazine; systemic, rectal

3.8

45.2

201

522

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

45.0

1602

10652

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.2

45.0

495

2255

130

Kela drug reimbursment

Malignant tumour

1.7

44.9

970

5657

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

44.8

284

961

D11

ICPC

Diarrhoea

1.7

44.8

932

5379

N06AB05

ATC

paroxetine; oral

2.0

44.8

579

2827

H36.01

ICD-10 Finland

Diabetic maculopathy

4.4

44.6

168

375

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

44.4

809

4477

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

44.2

225

652

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.2

44.2

476

2149

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

44.2

1231

7708

D64.8

ICD-10 Finland

Other specified anaemias

3.3

44.2

232

689

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.9

44.1

282

959

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

43.8

1055

6351

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.6

43.8

208

571

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.9

43.7

187

470

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

43.7

476

2159

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

10.9

43.6

102

Kela drug reimbursment

Diabetes insipidus

17.7

43.5

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

43.4

702

3730

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

5.9

43.3

125

208

WVA20

NOMESCO Finland

Medicine administration

3.0

43.2

263

867

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.8

43.2

297

1059

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

43.2

210

588

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

43.1

568

2794

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

10.6

43.1

G40

ICD-10 Finland

Epilepsy

5.2

43.0

138

260

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

42.9

195

517

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

42.8

331

1262

F05.8

ICD-10 Finland

Other delirium

5.4

42.8

132

238

L04AD01

ATC

ciclosporin; systemic

3.4

42.7

214

613

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

42.7

328

1248

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

42.6

285

999

R13

ICD-10 Finland

Dysphagia

1.9

42.4

692

3685

N18

ICPC

Paralysis/weakness

3.2

42.4

237

737

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.9

42.4

267

899

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

42.3

923

5399

L04AX01

ATC

azathioprine; systemic

2.2

42.3

450

2022

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

42.0

1011

6080

C09CA07

ATC

telmisartan; oral

1.8

41.9

753

4143

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

41.9

199

547

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

41.7

1088

6690

K02.1

ICD-10 Finland

Caries of dentine

1.3

41.7

5186

42787

SPAT1139

SPAT

Nutrition survey

2.4

41.7

382

1597

N05BA09

ATC

clobazam; oral

8.3

41.6

110

G44.2

ICD-10 Finland

Tension-type headache

1.6

41.6

1150

7183

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

41.6

437

1951

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

41.5

2600

19307

J01CA04

ATC

amoxicillin; systemic

1.3

41.5

8396

74029

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.5

41.5

151

326

WX704

NOMESCO Finland

Intubation

1.9

41.2

676

3609

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

41.1

333

1305

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

41.1

357

1451

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

41.0

622

3224

F32

ICD-10 Finland

Depressive episode

2.2

41.0

436

1958

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

41.0

440

1982

R10.0

ICD-10 Finland

Acute abdomen

2.5

40.9

343

1368

N06AX05

ATC

trazodone; oral

2.8

40.9

269

932

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.7

40.9

145

305

N03AX11

ATC

topiramate; oral

3.1

40.8

234

740

WX722

NOMESCO Finland

PEEP

2.1

40.8

491

2326

101

Kela drug reimbursment

Anterior pituitary hypofunction

6.9

40.5

104

148

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.5

40.4

194

538

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

40.3

717

3935

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.3

40.1

154

351

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.2

39.9

222

689

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

39.9

2316

16955

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.6

39.8

313

1205

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

39.8

470

2209

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.5

39.7

190

526

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

39.6

305

1161

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.7

39.6

287

1056

F03

ICD-10 Finland

Unspecified dementia

1.9

39.6

572

2913

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

39.5

389

1684

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

39.5

216

662

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

39.4

993

6046

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

39.3

303

1155

EBA30

NOMESCO Finland

Excision of root of tooth

1.9

39.3

574

2938

E000003

ATC

2.1

39.2

462

2170

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

4.7

39.2

137

284

C07AB03

ATC

atenolol; systemic

1.8

39.2

739

4129

S76

ICPC

Skin infection other

2.0

39.1

527

2613

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

39.1

318

1248

C10AC01

ATC

colestyramine; oral

2.6

39.0

290

1081

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

39.0

312

1214

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.7

39.0

175

459

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.8

39.0

114

193

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

9.2

39.0

F50.0

ICD-10 Finland

Anorexia nervosa

9.2

39.0

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

7.7

38.9

116

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

38.8

258

901

WX402

NOMESCO Finland

General anaesthesia

1.5

38.8

1450

9724

F20

ICD-10 Finland

Schizophrenia

6.4

38.7

104

158

SPAT1053

SPAT

Memory test

1.4

38.6

1807

12693

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.8

38.5

257

900

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.4

38.5

334

1357

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

12.9

38.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

38.4

917

5499

ZXA10

NOMESCO Finland

Bilateral

1.4

38.3

1997

14317

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

38.3

3427

26884

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

38.3

419

1906

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.0

38.3

157

381

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

38.2

359

1520

3AC01

NOMESCO Finland

4.2

38.2

151

354

L03

ICPC

Low back symptom/complaint

1.4

38.2

2248

16478

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

38.2

571

2947

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.4

38.1

343

1419

UJD02

NOMESCO Finland

Gastroscopy

2.0

38.1

546

2772

K65.0

ICD-10 Finland

Acute peritonitis

3.6

38.0

178

484

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

38.0

628

3358

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

38.0

308

1208

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

19.5

37.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

37.9

354

1494

C09DA06

ATC

candesartan and diuretics; oral

1.7

37.9

763

4350

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

37.9

421

1929

RS220

NOMESCO Finland

3.7

37.7

171

453

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.1

37.7

106

171

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.4

37.7

188

538

D10

ICPC

Vomiting

2.2

37.6

406

1835

Z00.8

ICD-10 Finland

Other general examinations

1.8

37.6

675

3715

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

37.4

2748

20897

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

37.4

3891

31169

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

37.4

573

2982

V03AE03

ATC

lanthanum carbonate; oral

10.8

37.4

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

37.4

287

1091

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

37.3

1197

7745

C02EA02

ATC

1.9

37.3

564

2921

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

12.8

37.2

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

4.7

37.2

131

274

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

37.2

391

1746

F50.9

ICD-10 Finland

Eating disorder, unspecified

6.7

37.1

142

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

37.1

217

698

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

+∞

37.1

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.3

37.1

143

328

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

3.4

37.0

184

525

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

6.7

37.0

139

H25.8

ICD-10 Finland

Other senile cataract

1.5

37.0

1325

8794

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.5

36.9

182

516

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

36.8

661

3634

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.2

36.8

145

339

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.8

36.8

249

879

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

36.8

396

1789

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.0

36.7

224

741

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.0

36.6

150

364

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

36.6

402

1831

P18

ICPC

Medication abuse

8.8

36.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.9

36.5

156

393

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

36.5

708

3992

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

36.4

613

3299

H3601, E103

ICD-10 Finland

5.4

36.4

113

206

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.3

36.4

114

210

H26.4

ICD-10 Finland

After-cataract

1.6

36.3

1104

7050

AN4

Balloon angioplasty and drug eluding stent

2.4

36.3

316

1285

E61.2

ICD-10 Finland

Magnesium deficiency

43.8

36.3

D07AB08

ATC

desonide; topical

1.6

36.3

1031

6475

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.2

36.0

142

333

A03FA02

ATC

cisapride; oral, rectal

1.7

36.0

886

5357

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.3

35.9

186

548

J94.8

ICD-10 Finland

Other specified pleural conditions

3.0

35.9

220

730

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

35.9

261

964

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.6

35.9

272

1029

C08CA10

ATC

nilvadipine; oral

2.6

35.8

263

976

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

35.6

312

1277

SPAT1281

SPAT

Other administrative function

1.7

35.5

790

4640

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.3

35.5

135

306

U14

ICPC

Kidney symptom/complaint

3.3

35.5

182

533

Z00.0

ICD-10 Finland

General medical examination

1.4

35.4

1819

12991

B03XA01

ATC

erythropoietin; parenteral

4.1

35.3

140

330

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

35.2

478

2380

N06AX12

ATC

bupropion; oral

2.1

35.2

425

2018

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

35.2

1908

13761

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

35.2

193

594

J01MA06

ATC

norfloxacin; oral

1.5

35.2

1443

9858

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

35.1

422

1999

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

35.1

735

4243

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.1

35.0

141

337

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.8

35.0

152

389

J01AA02

ATC

doxycycline; systemic

1.3

35.0

8458

75289

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

34.9

456

2235

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

6.0

34.9

162

M10.0

ICD-10 Finland

Idiopathic gout

2.3

34.9

336

1441

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.8

34.7

229

797

TAB00

NOMESCO Finland

Lumbar puncture

2.1

34.7

398

1847

D09

ICPC

Nausea

2.2

34.7

353

1552

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.3

34.7

133

304

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

34.5

568

3031

D12

ICPC

Constipation

2.2

34.4

381

1741

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.4

34.4

171

489

U08

ICPC

Urinary retention

2.9

34.4

222

763

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

34.4

565

3016

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.8

34.3

226

787

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.7

34.2

130

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

34.1

490

2491

B82

ICPC

Anaemia other/unspecified

2.5

34.1

287

1149

J02AC01

ATC

fluconazole; systemic

1.3

34.1

3546

28318

G04CA02

ATC

tamsulosin; oral

1.4

34.1

2375

17870

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.5

34.0

103

183

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.0

33.9

480

2424

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

6.7

33.9

128

R35

ICD-10 Finland

Polyuria

1.8

33.8

654

3683

R4120

NOMESCO Finland

Occupational therapy

1.8

33.8

568

3057

Z72.0

ICD-10 Finland

Tobacco use

2.8

33.6

225

790

L29.9

ICD-10 Finland

Pruritus, unspecified

2.6

33.6

254

960

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.4

33.4

301

1250

P74

ICPC

Anxiety disorder/anxiety state

2.5

33.4

272

1069

CKC12

NOMESCO Finland

Photocoagulation of retina

2.0

33.4

418

2015

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.6

33.3

172

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

33.3

1127

7375

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

33.3

497

2562

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

33.3

197

638

XF602

NOMESCO Finland

Bloodpressure monitoring

4.2

33.2

130

303

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.4

33.2

297

1229

SPAT1312

SPAT

General health counselling

1.3

33.2

3118

24529

SPAT1227

SPAT

Substance abuse rehabilitation

5.9

33.1

158

A10BB01

ATC

glibenclamide; oral

1.8

33.1

558

3004

R60.1

ICD-10 Finland

Generalized oedema

5.1

33.1

107

205

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

33.1

226

802

E23.03

ICD-10 Finland

Lack of ACTH

13.4

33.0

R06.4

ICD-10 Finland

Hyperventilation

3.3

33.0

171

505

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.9

33.0

138

342

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

10.2

33.0

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.6

32.9

155

425

XA400

NOMESCO Finland

EEG

5.5

32.8

175

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.8

32.7

221

782

N88

ICPC

Epilepsy

6.1

32.6

146

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.0

32.6

134

327

U02

ICPC

Urinary frequency/urgency

1.5

32.6

1262

8507

S00.0

ICD-10 Finland

Superficial injury of scalp

2.6

32.6

241

900

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

32.5

215

750

A10AB06

ATC

insulin glulisine; parenteral

4.2

32.5

127

296

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

32.5

341

1524

C10AA03

ATC

pravastatin; oral

1.7

32.4

679

3916

R52.2

ICD-10 Finland

Other chronic pain

2.2

32.4

332

1466

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.0

32.4

134

329

C09AA04

ATC

perindopril; oral

1.8

32.3

557

3019

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

32.3

208

711

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

32.3

387

1830

OAB43

SPAT

0.5

32.3

325

5802

E16.19

ICD-10 Finland

Other specified hypoglycaemia

7.7

32.3

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.2

32.2

126

294

S29

ICPC

Skin symptom/complaint other

1.4

32.1

1624

11541

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.2

32.1

178

553

H3601, E113

ICD-10 Finland

3.0

32.0

190

616

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

32.0

3373

26936

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.5

32.0

169

C09DA03

ATC

valsartan and diuretics; oral

1.9

32.0

504

2649

RD210

NOMESCO Finland

3.1

31.8

182

577

Z93.2

ICD-10 Finland

Ileostomy status

7.5

31.6

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

12.6

31.6

N05CD02

ATC

nitrazepam; oral

2.5

31.6

255

1000

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

31.6

316

1381

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

31.5

372

1747

R95

ICPC

Chron obstructive pulmonary disease

2.3

31.5

305

1311

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

31.5

2148

16075

N29

ICPC

Neurological sympt/complt other

2.7

31.5

221

798

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

31.5

173

534

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2263

9437

2.57

321.87

2.5

1.7

1.8

1.5

44.15

1862

8111

(3028271) Lactate [Moles/volume] in Capillary blood

774

1646

4.74

321.20

2.8

1.7

mmol/l

1.7

0.30

758

1606

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4016

21498

2.13

317.90

2.1

1.7

mg/l

1.6

1.3

2.94

3264

16455

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2504

11127

2.43

309.73

3.9

2.6

umol/l

10.3

9.5

0.85

2155

9658

(3022217) INR in Platelet poor plasma by Coagulation assay

3081

14976

2.26

309.70

26.6

27.2

inr

1.4

1.33

415

2092

(3030467) Casts [#/volume] in Urine by Automated count

5368

29688

2.21

307.65

4.9

3.0

e6/l

0.6

0.5

2.69

4508

22334

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9457

54527

3.10

307.65

9.4

5.9

umol/l

12.0

11.8

0.63

9021

51439

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1669

4669

3.78

307.65

1.7

1.6

g/l

1.6

1.5

2.79

1461

3937

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6425

31331

2.82

307.65

3.1

2.0

u/l

289.0

218.7

3.01

6094

29063

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

842

994

8.63

307.65

1.5

1.3

pmol/l

406.0

277.0

2.08

595

774

(3012501) Base excess in Blood by calculation

1003

2329

4.40

307.65

6.3

3.6

mmol/l

3.1

2.6

5.54

741

1573

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3858

20107

2.18

307.65

5.9

3.5

ng/l

289.2

482.0

1.85

3318

16256

(40767503) Oxygen content in Capillary blood by calculation

958

2160

4.52

307.65

3.7

2.3

15.4

16.2

6.19

516

1070

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3872

13557

3.43

307.65

3.9

2.3

20.6

22.3

9.58

3318

11371

(3013115) Eosinophils [#/volume] in Blood

8267

52202

2.30

307.65

8.2

5.8

e9/l

0.2

5.16

7385

45351

(3014576) Chloride [Moles/volume] in Serum or Plasma

3770

12834

3.51

307.65

10.7

6.1

mmol/l

101.0

104.5

145.13

3672

12601

(3019309) Folate [Moles/volume] in Red Blood Cells

4683

22043

2.58

307.65

2.1

1.7

nmol/l

1301.8

1168.7

13.69

3611

16226

(36304419) Bacteria [Presence] in Urine

5111

28733

2.13

307.65

4.9

3.0

—

(3019060) Gas panel - Arterial blood

2143

6992

3.31

307.65

7.0

4.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2269

6370

3.91

307.65

6.0

3.4

kpa

5.1

5.2

1.78

2135

5823

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4591

12340

4.86

307.65

9.4

4.6

mmol/l

1.1

1.0

11.71

4316

11287

(3013290) Carbon dioxide [Partial pressure] in Blood

1004

2330

4.40

307.65

6.3

3.6

kpa

5.0

0.11

975

2269

(3042936) Bacteria identified in Isolate by Culture

3323

14437

2.60

307.65

2.8

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

2575

9175

3.09

307.65

2.9

2.5

e9/l

72.1

68.1

5.51

2017

7008

(3037467) Urinalysis macro (dipstick) panel - Urine

10082

72678

2.23

307.65

7.2

4.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1954

4454

4.76

307.65

6.9

3.6

mmol/l

24.1

24.2

0.75

1768

3954

(3006315) Basophils [#/volume] in Blood

8127

50600

2.32

307.65

7.8

5.6

e9/l

0.0

0.61

7203

43271

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4069

14515

3.41

307.65

3.8

2.2

g/l

2.2

2.3

24.44

3763

13258

(3027801) Oxygen [Partial pressure] in Arterial blood

3463

11746

3.45

307.65

10.1

6.3

kpa

11.4

12.3

19.66

3294

11143

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6239

32656

2.53

307.65

4.2

2.9

ng/l

2679.8

1467.4

39.58

5512

27860

(3012544) pH of Venous blood

3563

9436

4.55

307.65

6.8

3.3

7.4

0.16

(3027273) Bicarbonate [Moles/volume] in Venous blood

1715

4921

3.69

307.65

6.6

2.9

mmol/l

24.9

25.3

3.11

1664

4781

(3016038) Potassium [Moles/volume] in Urine

1220

403

31.90

307.65

1.4

1.2

mmol/l

32.1

35.7

2.15

1052

330

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7442

41240

2.59

307.65

6.4

3.4

ng/l

85.3

63.0

0.55

6196

29694

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4481

17233

3.22

307.65

2.4

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1874

6505

3.05

307.65

13.1

7.7

93.3

93.9

3.02

1857

6484

(3011985) Renin [Units/volume] in Plasma

956

1027

9.56

307.65

1.9

1.3

mu/l

72.1

54.8

0.72

824

907

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1553

4201

3.89

307.65

2.4

1.9

ug/l

2.5

2.4

0.14

1361

3656

(3020630) Protein [Mass/volume] in Serum or Plasma

2331

8856

2.85

307.65

2.8

2.4

g/l

64.6

66.4

19.47

2111

7890

(3013650) Neutrophils [#/volume] in Blood by Automated count

8986

59006

2.33

307.65

12.9

8.7

e9/l

4.8

4.1

79.18

8051

51164

(3009343) pH of Capillary blood

2253

6279

3.94

307.65

6.0

3.4

7.4

1.74

390

800

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6588

32643

2.80

307.65

4.1

2.4

u/l

58.1

59.7

0.60

6181

29812

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1895

6561

3.07

307.65

11.1

6.4

mmol/l

24.3

24.7

2.60

1805

6091

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5610

30693

2.28

307.65

4.6

3.1

u/l

42.3

34.5

1.92

5292

28821

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7158

45183

2.09

307.65

2.5

2.0

pmol/l

91.3

95.1

8.65

4063

23010

(3022948) Iron [Moles/volume] in Serum or Plasma

4288

15791

3.34

307.65

3.8

2.2

umol/l

11.0

12.7

42.62

3958

14424

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7129

40678

2.42

307.65

4.3

2.6

ug/l

187.0

144.5

12.13

6536

36866

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2655

7380

4.05

307.65

2.0

1.6

—

(3022313) Gas panel - Capillary blood

1492

4624

3.36

307.65

6.4

3.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1614

4665

3.64

307.65

5.3

2.4

0.7

3.20

1590

4426

(42870588) Differential panel, method unspecified - Blood

6215

34631

2.32

307.65

7.3

5.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

2830

7620

4.24

307.65

5.9

2.8

kpa

4.6

4.5

2.96

2705

7364

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6902

42341

2.14

307.65

3.0

2.1

nmol/l

76.1

79.5

17.05

6209

37068

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1521

4632

3.43

307.65

7.1

3.5

49.8

47.3

3.36

1507

4575

(3004119) Hemoglobin [Mass/volume] in Venous blood

2062

6027

3.70

307.65

5.8

2.9

g/l

122.2

128.2

25.73

2021

5878

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3640

15046

2.81

307.65

2.6

2.0

30.3

29.9

2.43

3524

14572

(3027315) Oxygen [Partial pressure] in Blood

1008

2347

4.39

307.65

6.3

3.7

kpa

8.4

8.5

0.82

979

2286

(3010421) pH of Blood

1112

2710

4.21

307.65

6.5

3.5

7.4

2.69

975

2271

(3002030) Lymphocytes/100 leukocytes in Blood

7734

48426

2.22

307.65

8.4

6.0

23.3

27.3

168.01

7252

44468

(1616796) Gas panel - Central venous blood

1077

2134

5.19

307.65

5.1

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1026

2225

4.72

307.65

5.3

3.1

kpa

8.1

0.19

968

2056

(3015377) Calcium [Moles/volume] in Serum or Plasma

6171

36685

2.12

307.65

4.3

3.3

mmol/l

2.3

2.4

44.73

5358

31407

(3018095) Leukocytes [#/volume] in Urine

6358

37215

2.19

307.65

6.0

3.4

e6/l

127.5

113.0

0.42

5186

26412

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3465

11753

3.45

307.65

10.1

6.3

kpa

4.9

5.1

13.15

3303

11160

(3021901) Oxygen saturation in Capillary blood

857

1781

4.88

307.65

3.8

2.6

—

(3026782) Osmolality of Urine

5736

20474

3.90

307.65

3.8

2.6

mosm/kgh2o

443.0

554.2

265.66

5051

17215

(3035637) Corticotropin [Mass/volume] in Plasma

705

1018

6.98

307.65

1.6

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9680

53992

3.40

307.65

13.8

5.7

mmol/l

1.2

120.05

8119

44939

(3014111) Lactate [Moles/volume] in Serum or Plasma

3051

8622

4.09

307.65

9.6

5.9

mmol/l

1.5

1.4

2.90

2895

8300

(3024561) Albumin [Mass/volume] in Serum or Plasma

8660

46053

3.16

307.65

8.2

4.3

g/l

32.8

35.1

212.39

8127

42226

(3013826) Glucose [Moles/volume] in Serum or Plasma

10074

61507

3.11

307.65

10.1

4.2

mmol/l

7.1

6.7

51.21

9767

57303

(3003396) Base excess in Arterial blood by calculation

3485

11679

3.51

307.65

10.1

6.3

mmol/l

1.3

1.1

0.75

2772

9090

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2189

6079

3.93

307.65

5.9

3.3

mmol/l

2.0

1.9

0.43

1676

4537

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3510

9119

4.63

307.65

6.9

3.2

kpa

5.8

3.04

3376

8845

(3027945) Reticulocytes/100 erythrocytes in Blood

3312

12133

3.14

307.65

2.8

2.3

2.0

1.7

23.63

2909

10621

(3002032) Base excess in Venous blood by calculation

3501

9077

4.63

307.65

7.0

3.3

mmol/l

2.0

0.10

2897

7305

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3163

12064

2.98

307.65

3.7

4.2

u/l

248.9

247.4

0.16

2941

11338

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6007

26516

3.09

307.65

2.9

2.2

mg/l

3.2

3.1

2.30

5191

22416

(3018418) pH of Serum or Plasma

6198

31579

2.61

307.65

7.4

3.5

7.4

0.03

1543

5988

(3002582) Erythrocytes [#/volume] in Urine

5873

32102

2.32

307.65

5.2

3.0

e6/l

90.8

112.7

0.43

5008

24451

(3020779) Urea [Moles/volume] in Serum or Plasma

3332

8379

4.73

307.65

11.4

5.8

mmol/l

11.6

10.0

22.80

3176

7903

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1103

2434

4.66

307.65

4.5

2.8

mmol/l

24.4

25.1

3.79

999

2112

(3016502) Oxygen saturation in Arterial blood

3121

10444

3.43

307.65

10.6

6.6

95.1

95.6

2.99

3020

10025

(3022096) Basophils/100 leukocytes in Blood

7449

45668

2.23

307.65

8.1

5.9

0.6

0.7

21.57

7022

42057

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1866

6445

3.07

307.65

13.1

7.7

0.7

0.08

1852

6409

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2288

7350

3.40

307.65

5.6

3.1

ng/l

120.0

86.9

23.01

1941

6175

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1860

6473

3.04

307.65

13.1

7.6

1.4

1.43

1845

6433

(3031040) Bacteria [#/volume] in Urine by Automated count

10205

70626

2.48

307.65

7.9

4.5

e6/l

1146.4

1782.4

0.73

199

938

(3007853) Bacteria identified in Skin by Aerobe culture

2761

12047

2.51

307.65

2.4

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

4499

22596

2.36

307.65

4.1

2.4

e6/l

6.0

5.4

1.69

4113

19575

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

6929

38281

2.49

307.65

5.3

3.1

—

0.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2768

9556

3.24

307.65

11.4

7.0

g/l

116.8

120.8

17.88

2694

9196

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3085

11633

3.00

307.65

2.2

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1979

5948

3.57

307.65

1.8

1.4

—

(3024928) Oxygen saturation in Venous blood

854

1879

4.60

307.65

4.0

2.8

—

(3044640) Blood type and Crossmatch panel - Blood

5584

32724

2.08

307.65

3.7

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8993

49022

3.18

307.65

12.8

5.1

mmol/l

1.2

142.11

8399

43670

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1359

2913

4.88

307.65

1.5

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3101

11626

3.02

307.65

2.3

1.7

—

(3023368) Bacteria identified in Blood by Culture

7059

29104

3.72

307.65

6.4

4.0

—

(3018010) Neutrophils/100 leukocytes in Blood

7598

47654

2.19

307.65

7.9

5.7

61.3

57.7

106.54

7146

43967

(3023183) Ammonium ion [Moles/volume] in Plasma

1340

1792

7.87

307.65

3.4

2.5

umol/l

34.3

34.6

0.07

1145

1491

(3021960) Folate [Moles/volume] in Serum or Plasma

4879

25752

2.27

307.65

1.9

1.5

nmol/l

19.8

20.7

3.22

4317

21603

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1649

5246

3.30

307.65

12.1

8.0

mmol/l

24.2

24.4

1.30

1537

4831

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5712

15718

5.25

307.65

4.9

3.0

mmol/l

0.8

79.46

5382

14487

(3003181) Sodium [Moles/volume] in Urine

3079

1145

33.02

307.65

1.6

1.2

mmol/l

58.3

66.3

7.17

2432

884

(3032080) INR in Blood by Coagulation assay

7934

43812

2.74

307.65

13.5

9.2

inr

1.3

2.52

2543

12103

(3008295) Osmolality of Serum or Plasma

1321

728

19.23

307.65

1.5

1.4

mosm/kgh2o

268.1

284.1

49.59

1043

537

(3000991) Gas panel - Venous blood

2968

8115

4.21

307.65

11.8

7.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11031

81673

2.47

307.65

13.1

7.1

u/l

89.0

79.5

51.31

10569

76043

(3026008) Bacteria identified in Urine by Culture

6606

33916

2.67

307.65

4.7

3.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1379

3479

4.13

307.65

2.4

2.2

ug/l

583.4

601.8

0.06

1309

3252

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2133

5862

3.96

307.65

9.6

6.4

mmol/l

24.6

24.9

2.34

2102

5800

(3006504) Eosinophils/100 leukocytes in Blood

7629

47060

2.25

307.65

8.1

5.8

2.6

2.9

26.92

7190

43294

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4197

7712

7.08

307.65

2.3

2.2

nmol/l

400.6

371.6

10.09

3845

7038

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2819

9463

3.35

307.65

2.8

2.2

g/l

0.2

12.86

2544

8791

(3001604) Monocytes [#/volume] in Blood

8074

50321

2.31

307.65

7.8

5.6

e9/l

0.7

0.6

29.17

7163

43013

(3019069) Monocytes/100 leukocytes in Blood

7668

47340

2.25

307.65

8.5

6.1

8.9

8.7

4.04

7246

43747

(3019198) Lymphocytes [#/volume] in Blood

8193

51701

2.29

307.65

7.9

5.7

e9/l

1.7

1.9

15.19

7322

45039

(3020191) Ethanol [Moles/volume] in Serum or Plasma

457

610

7.43

307.21

1.9

1.3

promille

1.3

1.4

0.28

354

458

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1167

3458

3.46

306.59

3.8

2.8

u/ml

0.3

0.4

4.47

714

1957

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1685

6236

2.83

302.37

2.0

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1871

7328

2.69

300.90

2.5

2.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

920

2356

3.96

299.52

5.5

3.3

mg/l

1.9

1.5

24.84

841

2120

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7170

48018

1.91

291.69

5.9

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2453

11164

2.36

285.45

6.1

3.3

—

(3033658) Prothrombin time (PT) actual/Normal

4465

25679

2.00

284.64

7.1

3.7

84.8

87.8

10.69

4339

25035

(3018405) Lactate [Moles/volume] in Arterial blood

1192

3803

3.21

277.21

6.8

3.7

mmol/l

1.5

1.4

2.37

1161

3759

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1465

5292

2.87

273.82

13.8

8.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

637

1316

4.84

273.19

2.6

1.6

88.7

89.5

2.04

625

1295

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8711

62883

1.90

273.10

5.5

2.9

u/l

82.6

49.8

67.41

8084

57450

(3020891) Body temperature

1293

4415

3.01

267.34

9.6

4.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2138

9550

2.37

257.49

3.2

2.2

ug/l

6.1

7.0

1.24

1768

8177

(3005719) IgG [Mass/volume] in Serum or Plasma

1711

6913

2.58

256.06

3.0

2.8

g/l

10.6

10.7

0.14

1554

6302

(3034860) Kappa light chains.free [Mass/volume] in Serum

1060

3302

3.27

255.86

3.0

3.1

mg/l

125.5

62.9

0.57

829

2638

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1037

3189

3.31

255.61

3.0

ratio

4.2

5.2

0.13

229

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1058

3299

3.26

254.94

3.0

3.1

mg/l

44.7

46.6

0.14

821

2643

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1210

4104

3.02

252.68

7.3

3.6

mmol/l

24.9

25.0

0.43

1124

3742

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4281

25137

1.93

250.37

3.5

2.3

—

(3035350) Ketones [Presence] in Urine by Test strip

7312

50928

1.81

245.83

6.1

3.8

estimate

0.0

0.80

1789

9399

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4075

23748

1.93

242.27

1.9

1.7

pmol/l

14277615.2

33300664.1

2.12

3320

19129

(3009466) Valproate [Moles/volume] in Serum or Plasma

580

1243

4.65

237.63

5.6

4.4

umol/l

370.3

355.9

1.36

507

1031

(3009508) Creatinine [Moles/volume] in Urine

5097

32178

1.83

233.96

4.1

3.0

mmol/l

6.0

7.3

109.39

4253

26449

(3028026) IgM [Mass/volume] in Serum or Plasma

1398

5340

2.69

233.29

1.9

g/l

1.3

1.5

2.51

1257

4803

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2002

9046

2.32

233.13

4.0

2.3

u/l

32.9

54.3

1.55

1705

7724

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

844

2416

3.52

232.43

1.7

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3070

16439

2.03

231.76

4.3

2.8

e6/l

3.1

2.7

0.83

1907

8934

(3009261) Glucose [Presence] in Urine by Test strip

7338

51717

1.78

231.47

6.2

3.8

estimate

0.0

0.24

1766

9316

(3021601) Nitrite [Presence] in Urine by Test strip

7269

51092

1.78

231.42

7.9

5.0

estimate

0.0

1.08

1821

9444

(3020682) Albumin/Creatinine [Ratio] in Urine

5135

32739

1.81

226.28

5.0

3.7

mg/mmol

26.6

7.0

8.01

3486

19841

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1986

9122

2.28

221.73

7.5

3.2

mmol/l

1.2

24.23

1830

7767

(40760888) Immunoglobulin light chains.free panel - Serum

838

2480

3.40

218.91

3.0

3.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1918

8727

2.30

218.78

2.1

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

806

2352

3.45

215.18

1.8

1.6

—

(40758558) Short blood count panel - Blood

4254

25944

1.84

214.31

9.7

6.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1145

4128

2.82

212.84

7.4

4.7

1.7

1.6

0.60

1080

3846

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

679

1793

3.79

210.50

7.4

4.5

iu/ml

943.0

1492.5

0.27

115

260

(3000570) Elastase.pancreatic [Mass/mass] in Stool

917

2958

3.13

207.80

1.5

1.4

ug/g

237.1

274.2

5.46

570

1749

(3043409) Potassium [Moles/volume] in Arterial blood

978

3306

2.99

204.24

7.6

3.9

mmol/l

3.9

0.05

893

3162

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1975

9349

2.21

203.72

4.1

2.8

ng/l

326.3

218.3

10.42

1826

8492

(3012516) Albumin [Mass/volume] in Urine

4846

31100

1.77

203.48

4.1

3.0

mg/l

559.5

408.5

1.30

3363

19023

(3017181) Myelocytes/100 leukocytes in Blood

1883

8773

2.24

201.84

4.7

3.9

0.9

0.00

787

2477

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3200

18114

1.91

201.77

4.0

2.7

e6/l

1.4

1.3

0.03

2028

10511

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

919

3040

3.05

199.25

2.1

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4311

26912

1.79

197.75

3.7

2.5

umol/l

3076.0

5335.0

3.67

3682

22798

(3026250) Tacrolimus [Mass/volume] in Blood

247

266

9.10

197.74

43.1

30.2

ug/l

7.2

7.3

0.12

227

229

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

805

2504

3.23

193.62

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

767

2336

3.29

190.92

3.1

2.1

g/l

123.2

128.7

6.93

640

1645

(3019230) Fractional oxyhemoglobin in Venous blood

604

1591

3.78

187.67

4.2

2.6

62.5

63.6

0.47

596

1584

(3007930) Methemoglobin/Hemoglobin.total in Blood

1088

4079

2.71

186.89

7.5

4.8

0.9

0.06

1027

3797

(3025941) Bacteria identified in Stool by Culture

1277

5195

2.51

185.63

1.5

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3480

20756

1.82

183.40

3.7

3.1

mmol/l

2.5

2.27

3008

18119

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

510

1212

4.17

182.71

1.2

1.3

nmol/l

1.0

2.0

0.45

483

1158

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

510

1214

4.17

182.30

1.2

1.3

nmol/l

0.3

0.09

(3047181) Lactate [Moles/volume] in Blood

892

3050

2.94

182.03

8.2

5.6

mmol/l

1.5

1.3

2.82

794

2666

(3021589) Normoblasts [#/volume] in Blood

6365

45059

1.67

180.04

18.5

9.4

e9/l

0.0

0.71

5423

36873

(3021440) Promyelocytes/100 leukocytes in Blood

1754

8326

2.18

178.06

4.7

3.9

0.1

0.01

720

2285

(46235355) HIV 1 and 2 tests - Meaningful Use set

2253

11798

2.00

175.81

2.1

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2022

10190

2.07

175.41

2.1

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

530

1341

3.92

174.25

7.2

6.1

mg/l

12.8

11.7

4.62

484

1214

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

630

1802

3.48

172.97

1.8

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1087

4270

2.58

169.50

1.4

1.6

u/ml

8.7

17.5

1.52

113

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

537

1400

3.81

169.19

1.7

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9736

77674

1.70

166.70

5.1

3.8

pmol/l

15.4

14.9

43.63

8883

69160

(40760892) CBC W Ordered Manual Differential panel - Blood

3495

21417

1.77

165.35

6.6

4.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2960

17274

1.83

165.02

1.7

1.4

g/l

3.0

2.5

11.53

1877

9892

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

464

1110

4.13

164.65

1.2

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

124

21.53

162.70

1.2

1.5

pmol/l

14.2

18.2

0.18

101

(3013707) Erythrocyte sedimentation rate by Westergren method

9660

77224

1.68

160.56

5.6

4.1

mm/h

19.4

13.0

173.76

8935

70416

(3002179) Metamyelocytes/100 leukocytes in Blood

1657

7998

2.13

160.16

4.5

3.8

0.6

0.7

0.30

557

1799

(3029937) Albumin [Presence] in Urine by Test strip

4362

28622

1.68

160.02

6.8

4.2

estimate

0.0

0.50

1678

9113

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

448

1072

4.13

158.89

1.3

nmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5624

39682

1.62

152.96

6.7

4.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1114

4640

2.43

152.83

2.4

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

506

1363

3.68

151.90

4.2

2.5

u/ml

19807.6

7156.7

0.32

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

569

1656

3.41

151.85

5.6

2.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1040

4225

2.48

150.57

2.3

1.7

—

(3037756) Immunofixation for Serum or Plasma

677

2208

3.06

149.69

1.5

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

242

355

6.67

148.95

2.2

1.9

umol/l

107.4

128.7

0.42

136

186

(3013512) EKG study

4774

32592

1.63

147.01

5.9

3.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1001

4042

2.50

146.71

2.6

2.1

g/l

7.6

7.4

2.10

714

2946

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1000

4039

2.49

146.48

2.6

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

998

4031

2.49

146.17

2.6

2.1

g/l

3.8

0.29

696

2807

(3007566) Smooth muscle Ab [Titer] in Serum

702

2369

2.96

146.11

1.2

titre

123.0

156.0

0.36

186

(3025159) Blasts/100 leukocytes in Blood

1589

7803

2.09

146.01

4.8

3.9

0.1

0.3

0.89

596

1932

(3037522) Nuclear Ab [Titer] in Serum

2236

12386

1.88

145.15

1.4

1.3

titre

516.6

546.4

0.32

463

2730

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

740

2584

2.86

144.72

3.0

2.5

g/l

3.6

0.36

703

2454

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

580

1778

3.24

142.31

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

686

2322

2.94

141.95

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

686

2322

2.94

141.95

1.5

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

691

2365

2.91

140.12

1.2

titre

1408.1

915.8

0.70

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12026

103473

1.90

139.97

37.3

14.0

mg/l

26.7

25.3

5.74

11181

82128

(3042733) HLA Ab [Presence] in Serum

181

207

8.53

138.23

5.0

4.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

526

1553

3.35

137.11

1.7

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1189

5343

2.25

136.40

4.3

2.5

e6/l

0.4

0.3

0.58

1152

5210

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

937

3804

2.47

135.47

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1170

5258

2.25

134.12

3.0

pmol/l

4.1

4.4

20.48

1008

4617

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

641

2161

2.95

133.49

1.6

1.3

—

(40768446) Kidney Pathology biopsy report

197

260

7.40

133.49

2.2

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

929

3789

2.46

132.91

2.5

2.1

g/l

10.2

10.4

0.46

775

3091

(40768797) Stomach Pathology biopsy report

2418

14076

1.79

132.47

1.4

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

360

846

4.19

130.70

1.4

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

922

3776

2.45

130.68

2.6

2.1

g/l

3.2

3.1

2.29

702

2875

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2129

11973

1.84

130.50

3.8

4.0

ug/l

31.5

21.8

0.29

1814

9856

(3037121) Protein [Mass/volume] in Urine

877

3529

2.49

129.09

3.9

2.8

g/l

0.4

0.3

3.02

478

1347

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

528

1633

3.20

127.54

2.0

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

216

331

6.38

127.50

1.8

1.5

nmol/l

8.0

11.7

0.20

181

271

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

472

1382

3.37

124.59

1.6

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

122

12.89

124.17

4.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3136

20021

1.66

121.67

1.4

1.3

u/ml

2.0

1.8

0.18

782

5136

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

477

1430

3.29

121.22

1.7

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

824

3322

2.48

120.62

1.6

titre

185.6

259.0

0.37

170

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

519

1644

3.12

120.38

2.0

1.3

u/ml

14.7

17.5

0.26

(3028707) Methadone [Presence] in Urine by Screen method

332

783

4.16

119.94

3.3

2.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

500

1559

3.17

119.10

1.6

1.4

g/l

29.6

32.7

5.27

441

1387

(3041096) Erythrocytes [Presence] in Urine by Automated

3922

26668

1.58

116.67

6.0

3.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

413

1160

3.51

116.27

1.8

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

405

1126

3.54

115.80

9.4

11.2

mmol/l

7.5

7.2

0.66

359

919

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

477

1471

3.20

115.70

2.0

1.3

u/ml

115.7

120.9

0.36

128

331

(3036489) Thrombin time

805

3281

2.45

114.98

2.5

2.0

22.1

21.6

0.95

740

2868

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

562

1916

2.91

114.51

1.4

1.3

mmol/l

4.1

3.8

7.20

523

1796

(3010375) cycloSPORINE [Mass/volume] in Blood

209

346

5.90

114.21

30.3

26.2

ug/l

108.0

114.3

0.66

167

300

(40761536) Microorganisms panel - Urine sediment

1651

8964

1.88

111.82

7.0

4.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

521

1726

2.98

111.75

3.4

1.4

1.5

0.22

406

1321

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

817

3414

2.39

110.35

2.6

2.2

g/l

0.8

1.1

1.54

689

2845

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

461

1436

3.17

109.94

1.6

1.2

u/ml

284.2

280.5

0.09

307

882

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

607

2208

2.73

109.46

1.5

1.4

mg/l

596.6

555.5

0.35

576

2091

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

480

1543

3.07

108.49

1.6

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

680

2632

2.57

108.27

2.8

2.3

87.7

90.2

1.64

651

2462

(3011648) Oxygen content in Venous blood

287

656

4.29

108.03

3.7

2.6

10.3

10.9

1.67

287

656

(3023487) Leukocytes [#/volume] in Peritoneal fluid

204

349

5.70

107.74

2.8

1.9

e6/l

1069.5

2124.5

0.32

159

243

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

332

849

3.84

107.31

1.7

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

623

2324

2.66

106.89

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

449

1403

3.16

106.50

1.8

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

289

672

4.21

106.37

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

207

369

5.48

104.64

16.3

17.2

nmol/l

1471.4

1425.0

0.30

198

353

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

198

344

5.62

102.89

3.1

2.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

151

199

7.39

102.47

1.3

1.2

pmol/l

409.7

271.9

1.82

144

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

280

655

4.19

102.25

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

348

955

3.58

101.45

3.3

2.6

—

(3039000) Anion gap in Blood

588

2189

2.66

101.23

10.1

6.4

mmol/l

12.0

11.1

5.65

541

1939

(3018572) Chloride [Moles/volume] in Blood

588

2190

2.66

101.14

10.1

6.5

mmol/l

101.6

105.2

22.95

541

1940

(3011397) Hemoglobin [Presence] in Urine by Test strip

3591

24622

1.55

99.98

5.5

3.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10977

94327

1.58

99.70

6.3

4.6

mu/l

2.0

2.1

1.28

10127

84496

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

437

1400

3.07

99.31

1.9

2.1

32.7

32.5

0.35

431

1390

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

621

2399

2.57

99.17

2.8

2.5

224.4

195.3

9.41

591

2270

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

255

569

4.38

99.01

2.5

2.2

nmol/l

17.2

17.4

0.11

234

537

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

709

2919

2.41

98.79

2.6

2.1

g/l

0.0

0.03

644

2632

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

182

304

5.84

98.56

2.6

1.7

e6/l

9636.0

13420.4

0.22

115

170

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

341

943

3.55

98.26

1.4

1.3

—

35.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

744

3137

2.36

98.26

2.5

2.0

g/l

35.5

37.4

11.70

633

2614

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

196

353

5.42

97.99

11.3

12.5

nmol/l

781.4

850.1

0.90

187

331

(3044290) Cell count panel - Cerebral spinal fluid

502

1754

2.83

97.64

1.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

679

2757

2.45

97.52

1.7

1.6

g/l

1.1

1.2

2.04

639

2614

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

528

1898

2.75

97.31

1.5

e6/l

39.4

28.0

0.20

435

1504

(3052851) Hemolysis interference index of Serum or Plasma

734

3092

2.36

97.12

4.9

3.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

528

1900

2.75

97.11

1.5

e6/l

557.7

2450.4

1.01

460

1574

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

663

2669

2.46

97.01

1.7

1.6

g/l

0.2

0.31

620

2522

(3030313) Adrenal Ab [Titer] in Serum

18.44

95.75

1.1

—

(3012565) Volume of 24 hour Urine

213

423

4.91

95.37

2.1

1891.0

1917.5

0.11

181

361

(3048929) Epstein Barr virus Ab [Presence] in Serum

569

2151

2.62

94.94

1.5

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

159

241

6.42

94.88

1.8

1.4

g/l

12.2

13.8

1.03

125

180

(3019977) pH of Arterial blood

241

533

4.42

94.65

2.8

2.5

7.4

0.60

221

(44790049)

360

1057

3.34

94.52

1.7

1.5

—

(44806118)

360

1057

3.34

94.52

1.7

1.5

—

(44790047)

360

1057

3.34

94.52

1.7

1.5

—

(44790048)

360

1057

3.34

94.52

1.7

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

669

2746

2.42

93.78

1.4

1.5

iu/ml

16.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

463

1583

2.88

93.72

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

426

1393

3.01

93.41

1.6

1.4

e6/l

4519.0

2802.0

0.36

327

1010

(3000494) Fungus identified in Specimen by Culture

1960

11789

1.70

92.53

1.7

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

526

1938

2.68

92.37

1.3

1.2

titre

102.2

170.6

—

(37021550) Renin [Units/volume] in Plasma --upright

135

177

7.42

92.04

1.5

1.2

mu/l

169.8

54.2

1.22

130

(4198724)

145

211

6.68

89.96

2.8

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

279

715

3.82

89.90

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

207

422

4.79

89.87

2.5

2.2

95.9

96.5

0.08

201

402

(3033799) Differential panel - Peritoneal fluid

172

298

5.62

89.67

2.3

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

534

2020

2.61

88.93

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

283

742

3.73

88.25

2.3

2.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

655

2742

2.37

87.78

2.6

2.1

g/l

0.0

0.56

591

2462

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

349

1054

3.25

87.55

1.8

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

340

1014

3.29

87.05

1.3

mmol/l

6.8

6.3

2.71

316

927

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

644

2696

2.37

86.29

2.7

2.1

g/l

0.0

0.00

589

2454

(21494890) Protein electrophoresis panel - 24 hour Urine

336

1002

3.29

86.03

2.1

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

618

2556

2.39

85.08

3.5

3.1

nmol/l

0.9

0.8

2.23

456

1981

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

26.40

84.88

1.1

1.2

pmol/l

234.1

175.7

0.24

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1102

5719

1.93

84.52

1.6

1.3

—

(40761535) Cells panel - Urine sediment

1632

9555

1.73

84.43

5.4

3.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

292

810

3.53

83.75

1.9

1.8

g/24h

0.9

0.8

0.08

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

307

883

3.41

83.27

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

307

883

3.41

83.27

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

307

883

3.41

83.27

1.8

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

471

1729

2.68

83.26

3.4

1.6

nmol/l

0.9

0.8

2.00

384

1440

(3028308) Erythrocytes [#/volume] in Pleural fluid

386

1276

2.97

83.00

1.6

1.4

e6/l

51181.7

49820.2

0.04

249

755

(3019225) pH of Specimen

1895

11650

1.66

81.49

8.4

3.7

—

(40768806) Pleura Pathology biopsy report

372

1223

2.99

80.77

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

381

1272

2.94

80.49

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

382

1285

2.92

79.61

1.6

1.4

—

(3044007) Cell count panel - Peritoneal fluid

155

274

5.50

79.12

2.7

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

640

2775

2.28

78.97

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

641

2783

2.28

78.85

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

365

1204

2.97

78.78

1.6

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

392

1346

2.86

78.69

2.4

2.7

u/ml

179.9

1330.9

0.94

381

1316

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

167

319

5.10

78.24

2.9

2.8

umol/l

30.0

28.6

0.66

117

241

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

429

1556

2.71

77.62

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

320

987

3.18

77.53

1.8

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

384

1315

2.87

77.46

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

632

2749

2.27

77.38

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

375

1269

2.90

77.31

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

375

1271

2.90

77.09

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6812

54700

1.39

76.85

3.1

2.5

—

(3024471) HLA-A [Type]

143

241

5.77

76.78

1.0

—

(3024932) HLA-DR beta [Type]

140

232

5.87

76.49

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

373

1271

2.88

75.93

1.6

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

12167

108766

1.63

75.84

48.1

16.0

mmol/l

136.9

139.7

307.65

11953

105565

(3019150) Specific gravity of Urine by Refractometry

3251

22906

1.48

75.76

6.5

4.3

kg/l

1.0

8.56

515

3463

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

177

366

4.71

75.59

2.7

2.2

umol/l

58.3

55.7

0.38

145

287

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

207

485

4.16

75.48

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

207

485

4.16

75.48

1.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

330

1055

3.06

75.24

1.3

u/l

539.2

521.2

0.04

317

999

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

249

670

3.63

74.78

1.4

1.3

mmol/l

2.4

2.1

1.13

233

624

(3042631) Mycobacterium sp identified in Specimen

428

1589

2.65

73.95

2.6

2.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

330

1066

3.03

73.90

1.2

u/l

65.4

61.4

0.28

228

690

(3008037) Lactate [Moles/volume] in Venous blood

555

2340

2.34

73.05

5.4

3.0

mmol/l

1.6

0.12

546

2285

(3023103) Potassium [Moles/volume] in Serum or Plasma

12171

109032

1.61

72.47

48.0

16.1

mmol/l

4.0

0.97

11946

105614

(3016650) Hepatitis A virus Ab [Presence] in Serum

381

1350

2.77

72.10

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

390

1400

2.73

71.98

3.2

2.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

195

453

4.20

71.92

2.0

2.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

100

8.83

71.73

10.5

10.1

mmol/l

5.9

5.4

0.45

100

(3023419) Bacteria identified in Sputum by Culture

379

1347

2.76

71.31

2.3

2.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

559

2394

2.30

70.94

2.6

2.2

ug/min

183.4

81.0

4.54

340

1335

(3048689) Calprotectin [Mass/mass] in Stool

1731

10749

1.63

70.78

2.3

2.2

ug/g

207.6

140.7

6.45

1361

8291

(3036603) Volume of Urine

212

531

3.89

70.60

1.7

1.6

1929.5

1854.6

0.22

136

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

141

254

5.40

70.54

3.4

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

141

254

5.40

70.54

3.4

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

196

473

4.04

68.71

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

320

1070

2.93

67.42

1.6

1.5

—

(3011288) Drugs identified in Urine by Screen method

345

1203

2.81

67.30

4.3

2.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

458

4.02

65.90

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

237

673

3.44

65.62

1.8

1.4

—

(4035726)

1557

9588

1.64

65.50

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

518

2226

2.29

65.18

1.6

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

218

591

3.60

64.78

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

218

594

3.58

64.29

1.8

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

191

478

3.89

63.71

1.4

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

107

163

6.37

63.61

2.8

2.6

ml/dl

14.5

14.9

0.53

154

(3016879) Cocaine [Presence] in Urine

422

1678

2.47

63.23

3.3

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

240

704

3.33

63.15

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

167

382

4.25

62.90

4.6

4.2

mg/l

1181.1

1302.8

0.03

124

260

(3008757) Leukocyte morphology finding [Identifier] in Blood

335

1194

2.75

62.70

3.6

3.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

768

3896

1.95

62.52

3.1

3.5

u/ml

1398.2

1437.6

0.02

656

3322

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

370

1397

2.60

61.79

1.1

—

(3035880) pH of Pleural fluid

216

603

3.49

61.42

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

440

1811

2.39

61.11

3.3

2.1

—

(3044927) Protein electrophoresis panel - Urine

314

1097

2.80

61.04

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

253

6543

0.36

59.66

1.3

1.4

—

(3004451) EKG impression Narrative

180

454

3.86

59.42

1.5

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

151

334

4.40

59.40

3.2

1.6

umol/l

2.0

1.9

0.20

141

313

(3021387) Prolactin [Units/volume] in Serum or Plasma

460

1957

2.31

59.24

2.1

1.7

mu/l

386.7

287.9

4.35

425

1795

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

259

830

3.05

58.85

1.2

u/l

11.6

13.5

0.47

234

759

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

121

224

5.25

58.80

1.1

—

(3028300) Cannabinoids [Presence] in Urine

437

1827

2.35

58.58

3.5

2.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

524

2370

2.18

58.19

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

365

1414

2.53

57.81

2.1

1.8

ug/l

25.0

23.2

0.22

349

1377

(3027008) Opiates [Presence] in Urine

434

1823

2.34

57.56

3.3

1.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1382

8528

1.62

57.22

4.3

2.5

ml/min/173m2

52.6

64.0

18.82

674

3368

(3008116) Ketones [Moles/volume] in Urine by Test strip

103

171

5.84

56.24

1.7

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

30.61

56.20

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

218

650

3.27

55.91

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

495

2230

2.18

55.50

5.8

3.1

mmol/l

7.8

7.6

1.08

487

2181

(3017569) Oxygen content in Arterial blood

181

481

3.66

55.45

1.9

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

122

240

4.94

55.35

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

289

6810

0.40

55.11

1.6

1.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

160

392

3.97

55.02

1.3

58.9

66.8

0.46

(3014271) Vancomycin [Susceptibility]

212

631

3.27

54.54

3.6

3.0

—

(3027944) Amphetamines [Presence] in Urine

421

1787

2.31

54.50

3.2

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

364

1453

2.45

54.09

1.4

1.6

g/l

0.7

0.8

0.79

266

1082

(3044889) 12 lead EKG panel

8635

74019

1.33

53.92

5.5

3.8

—

(3016018) Differential panel - Cerebral spinal fluid

263

896

2.87

53.61

1.7

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

305

1124

2.65

53.51

3.2

3.6

64.0

58.5

3.22

186

731

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

240

4.85

53.41

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

242

793

2.98

52.92

1.5

1.4

u/l

14.1

12.9

1.62

232

757

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

216

664

3.17

52.71

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

204

608

3.27

52.38

2.4

1.8

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

21.48

52.29

1.1

1.2

mmol/l

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

150

364

4.01

52.28

3.1

1.5

umol/l

25.9

29.6

3.25

145

350

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

509

2381

2.10

51.81

2.9

3.3

u/ml

826.9

655.2

0.20

454

2156

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

737

3924

1.86

51.62

1.8

u/l

38.6

39.6

0.58

631

3428

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

316

1208

2.56

51.47

1.1

g/l

1.7

1.5

4.67

277

1079

(3000093) Morphology [Interpretation] in Blood Narrative

273

974

2.74

51.04

1.2

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

22.96

50.96

1.1

1.3

mu/l

58.0

25.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

112

220

4.94

50.93

1.5

1.3

g/l

23.5

59.4

0.72

170

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

201

612

3.20

49.86

1.1

1.0

mg/l

295.4

288.4

0.39

174

542

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

12.81

49.75

3.5

2.7

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

12.09

49.04

3.6

4.4

mg/l

2.2

2.5

0.34

(3017937) Magnesium [Moles/time] in 24 hour Urine

18.85

48.24

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

500

3.40

48.09

2.5

2.4

—

(3051651) Icteric interference index of Serum or Plasma

187

558

3.26

47.96

5.0

3.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

226

758

2.91

47.44

1.4

1.3

nmol/l

1.3

1.4

0.55

202

681

(3027923) C peptide [Moles/volume] in Serum or Plasma

166

464

3.48

47.20

1.4

1.3

nmol/l

1.2

0.02

124

365

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

262

959

2.67

46.62

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

732

4049

1.78

45.16

1.4

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

12.43

44.88

11.1

7.5

e6/l

181.3

432.7

0.41

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

155

432

3.49

44.30

2.9

2.7

ug/l

34.2

33.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

122

289

4.10

43.99

3.1

2.3

nmol/l

141.9

142.9

0.04

252

(3011412) CD3 cells [#/volume] in Blood

245

895

2.67

43.79

2.0

2.4

e9/l

1.1

0.32

159

541

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

119

278

4.15

43.71

1.3

1.4

pmol/l

18.2

15.8

0.84

230

(3045716) Anion gap in Serum or Plasma

157

446

3.42

43.57

2.4

mmol/l

8.6

9.0

0.42

124

338

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

484

3.31

43.54

3.6

2.8

—

(4062490)

250

927

2.63

43.38

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

162

471

3.34

43.36

1.6

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

151

421

3.49

43.14

1.5

1.4

61.1

65.1

0.68

121

349

(3017315) Amylase [Enzymatic activity/volume] in Urine

174

532

3.18

42.92

1.3

1.2

u/l

291.3

390.4

0.45

159

499

(3017704) Immunofixation for Urine

174

536

3.16

42.39

1.5

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

426

2017

2.07

41.99

1.7

1.6

iu/l

3.4

4.2

1.18

127

641

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

166

4449

0.35

41.96

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

185

597

3.01

41.64

1.3

1.2

u/l

103.9

86.3

1.33

163

500

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

193

640

2.93

41.41

1.6

1.5

u/l

8.3

6.5

0.45

288

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

235

866

2.64

41.31

1.4

1.6

u/ml

30.9

26.3

0.46

187

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

181

580

3.04

41.25

1.2

u/l

30.6

23.6

0.99

155

471

(3051611) Lipemic interference index of Serum or Plasma

272

1079

2.46

41.04

5.0

3.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

207

720

2.80

40.69

1.2

titre

86.9

163.6

1.91

137

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

109

253

4.18

40.41

2.3

2.4

ug/l

1.0

1.1

0.18

104

238

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

206

720

2.79

40.14

1.2

titre

75.0

177.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

245

937

2.55

39.95

1.4

1.3

g/l

2.6

3.0

2.00

167

637

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

354

1594

2.17

39.77

1.3

u/l

38.4

36.5

0.13

296

1365

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

125

5.73

39.76

2.4

2.9

mg/l

127.2

40.7

—

(3004775) Volume in Urine collected for unspecified duration

216

779

2.70

39.63

2.3

2.2

741.4

645.0

2.11

139

507

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10711

96162

1.32

39.56

8.3

5.7

mmol/mol

42.6

39.8

103.17

9828

87129

(3024139) IgG subclass 3 [Mass/volume] in Serum

244

936

2.54

39.54

1.4

1.3

g/l

0.4

0.32

166

638

(3027135) IgG subclass 1 [Mass/volume] in Serum

244

937

2.54

39.45

1.4

1.3

g/l

7.2

6.9

0.33

168

637

(40757494) Bilirubin.total [Moles/volume] in Blood

184

612

2.92

39.28

3.3

2.1

umol/l

20.8

35.4

0.84

(40761511) CBC panel - Blood by Automated count

11749

106996

1.38

39.14

34.6

13.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

397

1886

2.06

38.79

1.5

1.4

u/l

12.5

10.9

1.00

318

1531

(3042111) Morphology [Interpretation] in Bone marrow Narrative

372

1729

2.10

38.53

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

297

1271

2.28

37.79

1.1

iu/ml

85.2

8178.4

0.53

288

(3033705) Calcium.ionized [Moles/volume] in Venous blood

309

1347

2.24

37.62

3.9

2.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

130

360

3.51

37.58

1.4

3.3

2.7

0.34

112

300

(3002385) Erythrocyte distribution width [Ratio]

9410

83247

1.28

37.57

41.9

17.0

14.4

13.8

212.74

9262

81090

(3015171) Extractable nuclear Ab [Units/volume] in Serum

637

3569

1.76

37.54

1.2

u/ml

1.0

0.9

0.10

323

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

119

5.70

37.38

2.6

3.3

umol/l

37.4

42.4

1.00

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

526

2788

1.85

37.29

1.7

1.6

iu/ml

1.4

7.0

1.10

129

625

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

17.62

37.11

3.4

4.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

225

861

2.54

36.68

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

487

2533

1.88

36.63

1.7

1.8

mg/l

11.8

11.3

0.68

439

2339

(3000012) Reticulocyte production index

183

636

2.80

36.08

1.6

1.5

—

(3023410) Appearance of Cerebral spinal fluid

215

812

2.58

36.02

1.8

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

184

642

2.79

36.01

2.1

—

(3016750) Collection duration of Urine

167

553

2.93

35.98

2.3

2.1

min

512.4

497.1

1.06

116

403

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

186

4.53

35.85

3.2

2.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

118

318

3.60

35.56

1.3

1.4

21.8

20.6

0.18

109

285

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

17.05

35.35

3.4

4.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

955

6032

1.57

35.20

2.6

2.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

161

529

2.96

35.18

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

161

529

2.96

35.18

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

161

529

2.96

35.18

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

137

411

3.24

34.95

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

142

437

3.15

34.74

1.7

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

329

1520

2.11

34.64

1.4

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

101

249

3.93

34.58

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

199

739

2.62

34.52

2.1

2.2

41.2

41.6

0.04

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

160

530

2.93

34.47

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

207

788

2.56

34.14

1.7

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

190

700

2.64

33.50

2.0

2.1

73.8

71.1

1.44

183

668

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

111

5.58

33.49

1.9

2.0

umol/l

18.6

17.6

0.23

111

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

161

544

2.88

33.48

3.8

3.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

134

408

3.19

33.38

2.5

1.4

umol/l

15.9

26.1

4.55

127

387

(3035947) Staphylolysin Ab [Units/volume] in Serum

143

453

3.06

33.33

1.2

1.1

iu/ml

3.9

3.8

0.03

(3042517) Benzodiazepines panel - Urine

9.43

33.22

2.3

2.7

—

(3003694) ABO and Rh group [Type] in Blood

3343

26438

1.29

32.91

1.4

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

187

690

2.63

32.88

2.0

2.1

12.3

15.1

1.84

295

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

308

1416

2.12

32.87

1.2

1.1

—

(3022145) Colonoscopy Study observation

1606

11401

1.40

32.75

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

118

336

3.41

32.74

1.3

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

113

313

3.50

32.71

6.8

6.1

mmol/l

24.9

24.8

0.06

107

275

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

100

256

3.79

32.51

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

262

1135

2.25

32.43

3.1

3.4

nmol/l

11.1

12.3

0.08

253

1108

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12003

110327

1.36

32.19

42.7

16.4

umol/l

91.4

78.3

87.48

11997

110274

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

156

531

2.85

32.02

1.2

1.1

u/l

30.7

26.1

0.57

124

392

(3005322) IgE [Units/volume] in Serum or Plasma

852

5369

1.56

31.66

1.4

1.3

u/ml

367.0

243.5

1.21

782

4922

(3018133) Calcium [Moles/volume] in Urine

121

5.20

31.53

1.7

1.9

mmol/l

1.9

2.7

2.26

105

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

158

4.60

31.51

1.2

1.4

mu/l

494.4

1034.5

0.42

151

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

127

388

3.18

31.49

15.6

11.7

mmol/l

0.7

0.6

1.32

114

353

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.45

31.48

2.5

2.0

54.4

58.1

0.22

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

345

3.32

31.43

2.3

1.7

u/ml

384.1

29283.7

0.78

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

7.10

31.09

2.2

2.0

15.4

16.1

0.04

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

205

4.06

30.87

1.5

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

162

4.48

30.57

1.2

1.4

74.1

70.6

1.26

155

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

154

534

2.80

30.57

1.2

1.1

u/l

101.9

87.4

0.78

132

407

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

741

2.51

30.33

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

515

2886

1.75

30.32

1.8

1.7

—

(3010503) CD19 cells [#/volume] in Blood

163

585

2.71

30.30

2.1

2.4

e9/l

0.7

0.4

0.28

157

566

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

174

651

2.60

29.80

2.0

2.6

e6/l

1384.6

629.1

0.57

274

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

259

3.63

29.71

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

9.66

29.58

7.0

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

167

621

2.61

28.97

1.8

2.6

e6/l

704.0

506.6

0.43

140

521

(3006922) Hepatitis E virus Ab [Presence] in Serum

159

577

2.68

28.95

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

122

384

3.08

28.81

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

104

297

3.39

28.78

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

102

288

3.43

28.73

1.6

1.3

umol/l

3.1

3.6

0.80

266

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

263

3.54

28.32

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

101

5.36

28.15

1.7

2.0

mmol/l

1.5

1.6

0.08

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11964

110309

1.33

28.13

18.6

10.2

u/l

25.9

25.3

1.02

11641

105295

(3009542) Hematocrit [Volume Fraction] of Blood

10113

91324

1.25

28.11

35.3

15.3

36.2

39.3

138.01

5794

60537

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

143

499

2.78

28.09

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

143

499

2.78

28.09

1.3

1.5

—

(3000330) Specific gravity of Urine by Test strip

849

5496

1.52

27.87

5.8

3.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

183

4.07

27.79

1.6

1.2

umol/l

17.5

16.8

0.31

163

(40768441) Liver Pathology biopsy report

178

697

2.48

27.76

1.6

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

239

3.61

27.06

2.1

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

191

3.95

27.04

1.1

umol/24h

0.7

0.30

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10734

97743

1.26

26.84

34.1

13.2

ml/min/173m2

73.2

77.0

42.73

9506

80377

(3026389) Candida sp identified in Specimen by Organism specific culture

299

1467

1.99

26.82

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

260

3.47

26.63

1.9

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

106

323

3.18

26.47

1.1

miu/ml

1609.7

1477.1

0.52

106

323

(3012898) Urea [Moles/volume] in Urine

5.80

26.23

1.3

mmol/l

114.0

174.8

2.86

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

157

599

2.54

25.89

1.9

2.7

e9/l

0.2

2.20

140

518

(3026726) Creatinine [Moles/volume] in Specimen

5.93

25.70

2.8

2.0

umol/l

251.5

426.7

0.33

(3049717) Cytology report of Urine Cyto stain

696

4391

1.56

25.68

2.5

2.8

—

(3020393) Adenovirus Ag [Presence] in Stool

118

4.75

25.47

1.6

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

241

3.50

25.28

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

175

711

2.39

25.23

2.2

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

502

2948

1.67

24.92

6.6

4.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

144

537

2.60

24.90

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

156

4.16

24.88

1.5

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

504

2964

1.66

24.88

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

144

538

2.60

24.81

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

123

424

2.81

24.78

1.5

1.6

mmol/24h

8.7

5.8

—

(3025315) Body weight

6.55

24.63

5.5

5.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

168

678

2.41

24.60

2.8

3.6

nmol/l

198.8

155.8

0.53

161

664

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.82

24.44

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

655

4123

1.56

24.41

1.1

titre

370.5

176.1

0.38

105

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

167

4.00

24.34

1.4

8.7

11.7

0.57

(3023383) Lactate [Moles/volume] in Pleural fluid

106

341

3.01

24.19

1.3

mmol/l

3.6

3.4

0.21

309

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

175

725

2.34

24.17

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

128

458

2.71

24.04

1.2

—

(36660697) Celiac disease serology panel - Serum

1043

7253

1.42

23.62

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

122

4.52

23.57

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

14.16

23.51

3.4

3.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

36.25

23.46

7.1

9.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

269

3.24

23.25

1.2

—

(3022621) pH of Urine by Test strip

1015

7048

1.42

23.17

4.4

3.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

6.62

23.01

1.1

1.2

u/l

1130.5

1620.5

0.13

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

210

3.55

22.95

2.2

2.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

489

2914

1.64

22.94

1.7

—

(3017732) Neutrophils [#/volume] in Blood

1022

7137

1.41

22.58

4.3

2.9

e9/l

4.6

4.1

4.69

705

5289

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

202

916

2.14

22.48

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

200

3.58

22.36

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

270

3.16

21.81

1.3

30.2

20.6

0.42

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

552

3437

1.57

21.59

1.6

—

(3045142) Bone marrow Pathology biopsy report

230

1113

2.01

21.54

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

367

2.80

21.25

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

427

2.66

21.20

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

427

2.66

21.20

1.9

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

433

2.64

21.15

1.9

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

105

363

2.80

21.11

3.2

2.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

131

508

2.50

20.98

1.4

1.5

u/l

6.1

0.01

105

420

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

277

1441

1.87

20.97

1.8

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

352

2.81

20.59

1.8

1.4

iu/ml

2178150.8

1561232.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

154

649

2.30

20.53

2.1

2.0

umol/l

11.6

9.3

0.53

121

473

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

171

755

2.20

20.39

1.3

titre

383.3

543.3

0.41

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

4.44

20.25

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

288

1534

1.83

20.24

2.6

2.1

u/l

2842.7

4440.9

0.57

591

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

238

1193

1.94

20.18

1.3

1.2

u/ml

5.1

3.7

0.74

107

520

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

167

734

2.21

20.15

1.3

titre

31.0

71.9

—

(40757373) Influenza virus identified in Isolate

197

3.44

19.95

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

240

3.19

19.94

1.5

ug/l

0.3

0.4

0.75

153

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

209

1006

2.02

19.90

1.2

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

241

3.17

19.80

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

307

2.90

19.76

2.2

1.8

—

(4281824)

226

1122

1.96

19.72

1.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

698

4672

1.46

19.40

2.6

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

283

1523

1.81

19.25

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

127

506

2.43

19.24

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

118

4.18

19.17

2.1

—

(4027681)

112

422

2.57

19.09

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

104

378

2.67

19.05

2.0

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.49

18.95

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

138

576

2.32

18.85

1.4

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

280

2.94

18.71

1.4

1.3

23.0

23.8

0.09

234

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

133

3.93

18.68

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

212

1051

1.96

18.60

3.7

3.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

14.92

18.58

6.2

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

136

568

2.32

18.56

1.4

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

101

367

2.67

18.52

1.6

2.0

171.1

153.0

0.98

343

(3016244) Insulin [Units/volume] in Serum or Plasma

107

404

2.57

18.18

2.4

3.2

mu/l

21.0

25.9

0.64

100

377

(3021788) Differential panel - Synovial fluid

347

2016

1.68

18.04

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

133

558

2.31

17.98

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

15.44

17.77

6.4

9.1

e6/l

78.7

1134.6

—

(3052592) Norovirus Ag [Presence] in Stool

227

3.11

17.77

1.3

—

(3014891) Appearance of Pleural fluid

147

3.68

17.74

1.7

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

433

2675

1.58

17.58

1.8

1.6

e6/l

13756.7

14684.4

0.21

307

1944

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

239

3.04

17.52

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

211

3.16

17.28

2.0

2.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

137

593

2.24

17.23

2.5

1.9

u/field

1.4

3.1

2.13

106

387

(3000034) Microalbumin [Mass/volume] in Urine

181

873

2.01

17.21

3.5

2.7

mg/l

107.8

25.3

3.07

132

605

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

124

3.90

17.16

2.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

211

1075

1.91

17.12

1.6

1.5

21.1

29.6

3.69

127

650

(44786800) Granulocytes/100 leukocytes in Body fluid

152

3.56

16.91

1.4

21.0

23.1

0.18

119

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

113

4.02

16.83

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

314

2.71

16.76

1.2

1.3

ug/l

136.1

341.6

0.68

180

(3042010) Triglyceride [Moles/volume] in Pleural fluid

153

3.54

16.75

1.3

1.2

mmol/l

1.9

1.7

0.10

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

122

3.88

16.74

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

133

576

2.24

16.72

1.1

mg/l

297.0

284.3

0.26

115

505

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

791

5564

1.39

16.70

1.2

iu/ml

104.0

141.2

2.25

260

2013

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

6.29

16.62

1.7

1.6

ug/g

170.1

147.7

0.19

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

560

3703

1.48

16.59

1.1

u/ml

0.9

8.6

0.63

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

136

3.70

16.58

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

687

4730

1.42

16.42

1.8

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

137

606

2.19

16.37

1.2

mg/l

45.3

40.5

0.59

114

512

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

620

2.17

16.27

2.0

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.36

16.20

6.9

8.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.68

16.12

1.4

1.3

mg/l

63.1

41.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.53

15.88

1.1

umol/24h

1.9

1.7

0.50

(21491868) Cryoglobulin [Mass/volume] in Serum

329

2.62

15.84

1.3

1.2

g/l

0.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.83

15.77

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

227

1219

1.81

15.64

1.3

1.2

u/ml

4.4

4.3

0.04

413

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

133

3.63

15.58

1.3

1.2

u/l

228.9

98.5

0.61

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.94

15.53

7.6

3.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.17

15.44

1.6

1.8

umol/l

50.2

44.9

0.40

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

125

3.71

15.42

1.3

75.7

71.0

0.46

100

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1839

21256

0.81

15.33

2.9

3.2

ug/l

0.8

0.30

1323

14633

(3051593) INR in Capillary blood by Coagulation assay

127

560

2.20

15.32

7.2

11.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

205

3487

0.56

15.19

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

229

2.91

15.07

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

114

3.81

15.04

1.2

1.3

nmol/l

7.1

344219.0

0.91

(3041918) Cholesterol [Moles/volume] in Pleural fluid

209

3.01

15.01

1.2

mmol/l

1.5

1.7

0.40

119

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

132

597

2.14

14.96

1.3

1.4

umol/l

15.1

13.3

1.45

124

558

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

116

498

2.26

14.94

2.8

2.9

39.6

38.0

0.27

166

(3039443) Prostate specific Ag panel - Serum or Plasma

1824

0.40

14.91

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

102

3.98

14.87

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

2927

32287

0.84

14.85

3.7

2.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

242

2.84

14.79

1.1

84.7

86.0

0.09

125

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.91

14.69

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

180

917

1.90

14.68

1.6

1.4

u/l

31.9

29.8

0.28

142

750

(3046861) Legionella sp Ag [Presence] in Urine

4.99

14.51

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.10

14.37

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

4878

42653

1.16

14.35

2.3

2.2

—

(21494434) Karyotype in Bone marrow

177

904

1.90

14.34

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

247

2.78

14.26

1.1

84.6

85.3

0.05

124

(3022229) Phosphate [Moles/volume] in Urine

5.55

14.17

1.3

2.1

mmol/l

15.1

13.8

0.16

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

249

2.76

14.05

1.4

1.3

nmol/l

115.3

134.9

0.57

177

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

370

2324

1.55

14.05

1.1

u/ml

23.5

9.4

0.31

227

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.94

14.02

1.7

2.4

—

(3007461) Platelets [#/volume] in Blood

12207

114477

1.23

13.78

51.7

20.8

e9/l

257.2

246.5

44.12

11943

110788

(3006245) CD3-CD19+ cells/100 cells in Blood

330

2.49

13.75

2.2

2.3

10.1

11.7

0.55

300

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

236

2.79

13.73

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

122

3.56

13.68

1.2

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

12.28

13.68

1.5

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

170

3.13

13.62

1.8

1.1

—

(3024731) MCV [Entitic volume]

12208

114531

1.23

13.45

51.6

20.7

91.6

91.4

4.33

12027

112293

(3035941) MCH [Entitic mass]

12207

114525

1.23

13.42

51.5

20.7

30.4

2.07

12021

112290

(3010813) Leukocytes [#/volume] in Blood

12210

114557

1.23

13.41

51.9

20.8

e9/l

7.5

6.7

104.07

11910

110443

(3026361) Erythrocytes [#/volume] in Blood

12208

114542

1.23

13.37

51.8

20.8

e12/l

4.1

4.5

307.65

11906

110425

(3017509) Phencyclidine [Presence] in Urine

5.21

13.28

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

407

2.31

13.24

1.1

u/l

1.0

1.1

0.33

195

(3000963) Hemoglobin [Mass/volume] in Blood

12208

114560

1.23

13.23

52.3

20.9

g/l

124.5

134.5

307.65

12024

112335

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

184

2.99

13.13

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

182

966

1.83

13.11

2.3

2.2

u/field

2.3

2.1

0.17

341

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10895

101228

1.17

13.04

5.7

4.7

mmol/l

6.3

6.0

78.77

9762

90459

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2001

16375

1.21

12.84

1.3

iu/ml

41.3

37.8

0.40

639

5124

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

318

2.46

12.83

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

21.72

12.62

3.8

5.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

120

3.46

12.54

1.1

u/l

15.9

18.6

0.53

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1819

14784

1.21

12.51

16.9

7.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.75

12.44

2.7

3.2

mg/l

1.5

1.3

0.34

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

253

1501

1.64

12.28

2.7

2.1

mg/l

31.1

26.1

0.56

393

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.14

12.11

1.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

284

1743

1.58

12.00

1.8

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

289

2.48

11.88

1.9

3.0

—

(3044941) Cell count panel - Synovial fluid

277

1696

1.59

11.83

1.6

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

125

3.32

11.80

4.3

2.5

u/field

0.6

0.07

125

(3033086) Enterovirus NOS Ab [Titer] in Serum

7.46

11.73

1.0

—

(4146454)

194

1086

1.73

11.73

2.9

2.6

—

(3007463) Buprenorphine [Presence] in Urine

9.65

11.72

3.0

12.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

4.93

11.57

1.2

1.1

u/l

55.4

41.9

0.40

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

199

1129

1.71

11.48

1.1

119.9

116.2

0.68

176

1013

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.32

11.35

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

360

2360

1.48

11.26

3.2

2.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.50

11.23

1.0

1.1

u/field

1.4

1.0

1.83

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

391

2611

1.46

11.13

1.3

u/ml

71.8

42.8

0.73

159

(3006270) Folate [Moles/volume] in Blood

172

945

1.76

11.13

1.2

nmol/l

335.7

338.0

0.04

130

762

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.73

11.10

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

234

1399

1.62

11.06

1.6

67.0

59.7

2.11

141

870

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

385

2.21

10.97

1.1

ng/l

581.0

517.8

0.07

(3010370) Gastrin [Moles/volume] in Serum or Plasma

137

3.10

10.84

1.6

1.5

pmol/l

47.6

59.8

0.44

108

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

107

508

2.04

10.82

1.5

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

363

2406

1.47

10.76

1.3

u/ml

5.9

6.1

0.02

269

(4306422)

201

1170

1.67

10.57

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

466

6138

0.72

10.53

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

203

2.67

10.51

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

137

716

1.85

10.48

1.8

1.9

mmol/l

7.7

7.0

1.19

488

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

158

866

1.77

10.34

1.7

1.4

nmol/l

0.3

0.54

121

631

(4268621)

149

804

1.80

10.28

2.3

2.2

—

(3048879) Bone marrow aspiration report

353

2.22

10.22

1.5

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

240

2.50

10.21

2.1

2.3

e6/l

144.3

855.7

1.29

130

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

173

977

1.72

10.20

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

147

792

1.80

10.20

2.1

1.8

mg/l

5.5

3.9

2.54

136

745

(3023420) DNA double strand Ab [Units/volume] in Serum

167

935

1.73

10.16

1.6

1.5

iu/ml

44.8

23.4

0.56

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

124

636

1.89

10.07

1.2

1.3

mmol/l

10.4

11.8

1.49

164

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

362

2432

1.45

10.03

1.3

u/ml

4.6

4.9

0.08

423

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

248

2.46

10.02

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

311

2029

1.49

10.01

1.3

1.2

u/ml

4.2

5.1

0.19

162

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

379

2571

1.43

9.97

1.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

673

5016

1.31

9.78

4.4

3.7

u/ml

89.5

72.0

0.60

647

4817

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

106

3.28

9.74

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.53

9.68

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.08

9.59

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

148

2.87

9.53

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

192

2.62

9.45

2.1

1.3

ng/l

151.1

103.5

1.32

192

(4010399)

979

7680

1.25

9.40

1.5

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

361

2.14

9.30

1.1

u/ml

33.4

17.1

0.37

(40768443) Skin Pathology biopsy report

655

4907

1.30

9.18

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

198

1193

1.61

9.15

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

206

1256

1.59

9.07

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

391

2.08

9.03

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

131

713

1.78

8.85

1.6

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

5.11

8.69

1.8

5.4

16.3

12.4

—

(3028717) Thiamine [Mass/volume] in Blood

3.41

8.64

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

764

5887

1.27

8.59

1.2

1.3

au/ml

53.5

53.1

0.01

272

(3001964) Herpes simplex virus Ag [Presence] in Specimen

279

2.25

8.58

1.5

1.3

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

2.0

4.2

0.73

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

5.3

3.2

0.48

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

1.0

1.8

0.36

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

2.2

0.00

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

1.0

2.1

0.63

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

3.5

2.4

0.31

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

2.2

1.4

0.35

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

0.3

2.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.41

8.57

1.3

1.6

mg/l

0.7

1.7

0.54

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

110

3.07

8.56

1.1

1.0

—

(4024509)

189

1147

1.60

8.52

1.9

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

244

2.34

8.49

2.2

2.4

mmol/l

7.3

0.02

143

(3023323) Follitropin [Units/volume] in Serum or Plasma

369

2568

1.40

8.46

1.6

1.4

iu/l

28.2

32.3

1.39

307

2215

(3034891) Synovial lining cells/100 cells in Synovial fluid

106

549

1.87

8.43

1.6

1.5

1.7

3.3

1.88

125

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2759

29510

0.88

8.41

4.1

4.5

21.9

0.02

1336

15356

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

170

2.61

8.39

1.3

1.2

85.8

77.8

0.46

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

270

2.26

8.35

1.1

1.3

116.2

112.4

0.49

244

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

275

1819

1.47

8.34

1.3

miu/ml

192.5

213.2

0.29

761

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

177

2.57

8.26

1.9

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

829

6480

1.25

8.24

2.3

2.4

au/ml

22.3

25.9

0.24

283

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

150

2.70

8.19

1.2

41.1

52.5

0.59

(3026480) Teichoate Ab [Titer] in Serum

3.22

8.19

1.1

1.0

—

2.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

156

2.66

8.14

1.3

ng/l

101.2

679.2

0.59

106

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.22

8.14

1.3

1.6

mg/l

2.3

1.6

0.20

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

447

1.95

8.14

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.59

8.09

1.1

1.4

43.1

35.9

0.27

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

118

642

1.78

8.03

1.2

1.3

u/ml

0.8

1.4

0.51

317

(3038071) Oxygen [Partial pressure] in Mixed venous blood

180

2.52

8.00

18.0

6.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

103

539

1.85

7.96

1.1

nmol/l

4.7

8.3

0.32

118

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

146

849

1.67

7.84

1.1

100.4

94.3

1.91

133

791

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

217

2.36

7.83

17.2

7.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

2.78

7.82

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

329

2278

1.40

7.81

1.2

1.1

—

(40763791) Oxygen content in Venous blood by calculation

5.15

7.79

2.2

5.4

ml/dl

12.7

11.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

166

2.56

7.73

2.6

2.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

174

1066

1.58

7.59

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.97

7.54

1.9

2.0

pmol/l

241.2

16.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

289

2.14

7.52

1.1

1.3

g/l

0.3

2.22

230

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

4.11

7.49

1.8

1.4

u/field

1.2

1.1

0.08

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.11

7.49

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

277

2.16

7.48

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

114

2.88

7.47

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

5.63

7.47

1.1

1.0

umol/24h

0.2

0.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.39

7.47

1.6

1.3

ml/s/173m2

0.8

1.0

0.59

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

161

976

1.60

7.36

1.8

1.7

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.90

7.35

1.0

1.2

ng/l

10837.4

3323.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

126

2.76

7.33

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

171

2.49

7.30

1.3

1.2

72.8

72.9

0.01

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.11

7.28

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

2.87

7.22

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

480

1.85

7.22

1.1

ratio

1.1

0.54

167

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

269

1825

1.43

7.20

1.2

1.3

u/ml

56.0

46.8

0.33

198

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

+∞

7.19

2.1

0.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

112

2.85

7.11

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.46

7.11

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

355

1.99

7.07

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1815

15456

1.15

6.97

1.3

1.2

u/ml

11.8

14.6

0.85

622

5686

(4034850)

461

3425

1.31

6.96

16.3

10.7

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.07

6.90

1.4

1.1

33.6

24.9

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.47

6.85

2.5

3.3

—

(3024263) Appearance of Synovial fluid

104

575

1.75

6.78

2.0

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

172

1081

1.54

6.76

1.5

1.4

e6/l

20153.6

147186.4

6.92

123

738

(3019420) Tryptase [Mass/volume] in Serum or Plasma

457

1.84

6.72

1.2

1.6

ug/l

8.5

10.0

0.34

409

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

210

2921

0.69

6.66

2.3

1.6

mg/l

3.9

3.5

0.24

168

2047

(3003129) Base excess in Capillary blood by calculation

278

2.09

6.65

1.9

mmol/l

0.6

0.01

263

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

397

1.90

6.64

1.1

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

187

2.32

6.49

2.8

u/l

3447.6

1858.4

0.30

172

(3008536) Aspergillus sp Ab [Presence] in Serum

200

2.27

6.43

2.0

1.9

—

(40768800) Prostate Pathology biopsy report

169

2432

0.67

6.42

1.2

—

(3019174) dRVVT (LA screen)

3.31

6.41

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.74

6.32

1.2

1.1

u/l

1.6

4.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

246

2.12

6.27

1.1

—

(4212803)

2.93

6.16

1.1

1.0

—

(44806420)

307

1.98

6.12

2.4

2.5

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

151

2.43

6.07

1.6

1.5

ug/l

107.2

118.8

0.27

126

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

517

1.74

6.00

2.2

ug/min

168.0

62.8

0.79

109

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

267

2.03

5.80

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

124

756

1.59

5.64

1.5

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

174

1146

1.47

5.56

1.2

1.3

u/ml

31.8

61.8

1.41

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

326

2388

1.32

5.54

1.4

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.40

5.52

1.4

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

134

838

1.55

5.48

1.2

u/ml

29.2

38.1

0.37

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.79

5.47

3.1

2.6

—

(3049233) Organic acids panel - Urine

12.40

5.45

1.2

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

133

836

1.54

5.33

1.2

u/ml

79.2

75.2

0.08

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

176

1175

1.45

5.26

3.7

3.8

u/ml

112.8

47.4

1.30

170

1151

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

291

1.93

5.24

4.7

5.3

63.6

70.6

0.86

227

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

121

2.47

5.19

14.0

9.6

umol/l

0.3

0.5

0.42

113

(3022689) Creatine [Moles/volume] in Urine

246

2.00

5.16

2.3

1.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.36

5.06

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

364

1.81

5.05

1.5

1.3

70.6

55.4

3.06

309

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

110

671

1.59

5.05

4.1

4.5

u/ml

151.8

132.4

0.06

188

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

126

794

1.53

5.02

1.2

u/ml

4.0

3.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

135

2.36

5.01

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

135

2.36

5.01

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

135

2.36

5.01

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

134

859

1.51

4.94

1.3

1.2

u/ml

42.6

58.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

110

676

1.57

4.90

1.1

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.51

4.89

1.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

109

671

1.57

4.83

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

109

672

1.57

4.80

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.43

4.74

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.43

4.74

1.7

1.3

umol/24h

371.4

335.1

0.27

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

221

2.01

4.74

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.74

4.73

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

109

675

1.56

4.72

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

109

675

1.56

4.72

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

228

1.99

4.72

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

160

1074

1.44

4.70

1.1

u/ml

4.1

3.5

0.15

415

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

496

1.66

4.69

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

108

671

1.56

4.62

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

623

5039

1.20

4.57

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

2.81

4.54

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

112

2.41

4.49

1.2

ug/l

142.5

110.2

0.49

(3035320) C reactive protein [Mass/volume] in Body fluid

117

748

1.51

4.41

3.6

2.4

—

(3000492) Spirometry study

1029

8711

1.15

4.32

1.6

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

121

2.31

4.26

1.9

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.86

4.25

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

908

10014

0.87

4.23

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.94

4.22

1.1

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.15

4.19

1.1

1.2

1.5

0.09

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

445

1.65

4.18

5.3

6.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.76

4.18

1.0

—

(3002256) Pathology report gross observation

1586

13837

1.12

4.14

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

260

1.86

4.14

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

260

1.86

4.14

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

260

1.86

4.14

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

260

1.86

4.14

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.08

4.12

1.0

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

182

2.02

4.00

1.1

—

(4015189)

341

1.73

4.00

2.5

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

169

2.06

4.00

1.0

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.85

3.99

1.1

1.3

28.7

11.4

1.01

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

760

0.54

3.97

1.3

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

278

1.81

3.96

2.2

1.8

u/l

19.2

46.2

1.76

257

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.03

3.94

1.1

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

110

713

1.49

3.93

1.1

—

16.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.74

3.93

1.1

1.0

—

(3036180) Methadone [Presence] in Urine

9.65

3.91

2.3

3.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.41

3.88

1.2

1.4

—

248.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.19

3.87

1.0

—

(3000285) Sodium [Moles/volume] in Blood

152

2.10

3.86

1.5

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

253

1.83

3.84

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

119

1639

0.70

3.77

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

141

2.12

3.75

8.4

7.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.41

3.73

7.0

4.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.66

3.59

1.5

1.6

nmol/l

352.5

608.9

0.98

(3045683) HLA typing for celiac disease panel - Blood or Tissue

435

1.60

3.56

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

184

1.94

3.55

3.2

5.2

u/l

32.4

78.8

1.12

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.40

3.54

1.0

—

(4094501)

207

2588

0.77

3.51

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

145

2.06

3.51

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

268

1.77

3.51

1.3

1.7

ug/l

10.5

8.8

1.18

268

(3038177) Helicobacter pylori Ab [Presence] in Serum

193

1412

1.32

3.47

1.3

1.2

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

7.50

3.46

4.4

1.6

umol/l

23.4

29.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

715

0.57

3.46

1.6

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.55

3.46

1.2

1.1

u/l

7.3

12.6

0.71

(3047352) Trisomy 18 risk [Likelihood] in Fetus

699

0.56

3.40

1.6

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1227

13083

0.89

3.39

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

546

4505

1.18

3.29

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.82

3.26

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

118

2.13

3.20

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

914

0.63

3.20

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.66

3.18

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.57

3.16

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.13

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.41

3.12

1.8

1.6

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.41

3.12

1.7

1.8

0.6

0.7

0.10

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

200

1.83

3.12

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

214

1.80

3.11

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.68

3.03

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1039

0.67

3.00

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.22

3.00

1.5

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.57

2.99

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

106

724

1.41

2.99

1.0

ng/l

760.4

715.3

0.48

463

(3005033) Fetal Nuchal fold Thickness US

694

0.60

2.95

1.6

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10191

96512

1.07

2.94

4.7

3.9

mmol/l

1.3

22.94

9086

86129

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

351

1.60

2.92

1.1

1.0

100.9

95.1

0.74

272

(3028468) Fragments [Presence] in Blood by Light microscopy

9.64

2.91

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

106

728

1.41

2.90

1.0

ng/l

30.1

46.4

6.34

476

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

105

722

1.41

2.86

1.0

ng/l

568.5

346.8

0.29

481

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

562

0.57

2.80

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

5.19

2.78

1.7

3.8

mu/l

5.4

2.5

—

(3001729) Color of Synovial fluid

2.18

2.78

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

664

5644

1.14

2.74

1.9

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

265

2086

1.23

2.72

1.7

1.4

pmol/l

302.7

176.2

1.16

251

2038

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

843

0.65

2.72

1.5

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.82

2.67

1.0

mmol/l

4.7

5.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

698

0.62

2.66

1.4

1.3

pmol/l

48.4

112.2

0.80

209

(3034426) Prothrombin time (PT)

285

1.63

2.64

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

847

0.66

2.62

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

813

7023

1.12

2.61

2.5

2.1

nmol/l

10.9

12.5

5.95

657

6187

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

846

0.66

2.60

1.5

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.06

2.58

1.1

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

843

0.66

2.56

1.5

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

265

1.64

2.56

2.0

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

289

2312

1.21

2.55

5.2

3.4

mg/l

28.0

29.6

0.33

206

1448

(36303858) Crystals [Presence] in Urine

4.50

2.51

1.0

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.50

2.51

1.3

1.2

g/l

0.1

—

(44806071)

104

2.04

2.50

1.2

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

6.89

2.48

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

6.89

2.48

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

6.89

2.48

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.07

2.47

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

175

1.76

2.39

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

148

1.83

2.34

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

290

0.46

2.25

2.2

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

758

6585

1.12

2.25

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.13

2.17

1.6

1.2

nmol/l

27.0

14.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.13

2.17

1.1

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

125

1.85

2.12

2.4

2.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

112

1.90

2.08

28.3

7.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.13

2.08

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.13

2.08

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

4.13

2.08

1.3

1.1

—

25.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

2.07

0.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

677

0.67

2.06

1.6

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

380

0.56

2.05

1.5

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.09

2.01

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.86

1.97

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.38

1.88

1.6

1.4

mmol/24h

1.8

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

497

1.38

1.87

1.5

ug/l

2.4

5.0

1.60

389

(3018291) Platelet Ab [Presence] in Serum

3.62

1.86

1.5

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

4.02

1.76

1.0

—

(1002224) Polysomnography panel

278

3111

0.86

1.76

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

127

1.75

1.73

1.6

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.31

1.71

1.4

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.31

1.71

1.4

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

894

0.74

1.70

10.5

2.7

14.0

13.2

3.68

879

(3032868) Hemoglobin electrophoresis panel in Blood

2.01

1.70

1.7

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

273

1.48

1.67

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.57

1.64

63.5

6.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

315

2652

1.15

1.63

1.9

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

234

2632

0.85

1.61

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.14

1.60

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

157

1250

1.21

1.59

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

209

1711

1.18

1.57

3.9

3.7

u/ml

53.0

44.7

0.26

201

1658

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.44

1.56

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

3.44

1.56

1.2

1.3

mg/l

2.6

1.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

125

1.70

1.53

1.3

1.5

—

(4211845)

575

1.31

1.52

5.3

3.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

345

0.61

1.50

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.96

1.50

1.1

—

(3006462) Nitrate [Presence] in Urine

537

1.31

1.46

5.3

3.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

208

0.51

1.45

1.7

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

158

1.59

1.42

1.5

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

757

0.75

1.41

1.1

1.0

u/ml

0.1

0.3

0.84

180

(3047007) Chlamydophila sp Ab [Presence] in Serum

150

1206

1.20

1.41

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

833

0.76

1.41

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

214

1.49

1.37

2.2

2.9

au/ml

148.2

149.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

215

1.48

1.34

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.14

1.34

1.2

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.14

1.34

1.1

nmol/l

194.1

249.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

901

0.78

1.33

1.1

u/ml

1.9

4.0

1.35

343

(3034614) HLA Ag [Interpretation]

2.84

1.30

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.90

1.30

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1080

0.80

1.30

1.2

1.1

u/ml

0.5

2.0

3.19

243

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

226

1.45

1.27

2.7

3.5

mg/l

6.1

7.5

0.71

186

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.93

1.25

1.4

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

103

1.69

1.25

1.4

1.1

—

(3013762) Body weight Measured

2.68

1.23

1.0

1.3

—

(40758292) HTLV I+II Ab panel - Serum

149

1.55

1.23

1.5

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1529

14046

1.06

1.22

5.0

4.4

34.5

32.8

6.33

1076

9169

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

258

2200

1.13

1.19

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

633

1.25

1.18

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

271

1.39

1.17

1.6

1.3

23.8

34.6

1.28

183

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.01

1.17

1.4

1.6

—

(44813793)

635

1.25

1.15

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

681

1.23

1.12

1.5

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

178

1.46

1.08

1.7

2.9

ng/l

157.3

162.3

0.02

(3009871) Measles virus Ab [Titer] in Serum

251

1.38

1.08

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

221

1.40

1.02

1.4

1.2

mg/l

0.8

51.0

0.99

171

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.93

0.96

1.9

1.5

ug/l

128.0

73.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

363

1.28

0.88

1.3

1.2

g/l

37.8

39.5

0.25

189

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.79

0.87

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

123

1.49

0.86

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

318

2807

1.09

0.86

2.0

1.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.50

0.81

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

100

1120

0.86

0.79

1.2

mmol/l

8.2

7.6

1.09

792

(3023430) Cat dander IgE Ab [Units/volume] in Serum

829

0.84

0.79

1.1

u/ml

2.4

4.0

1.01

317

(3037556) Urate [Mass/volume] in Serum or Plasma

337

1.26

0.75

1.7

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

103

0.56

0.72

3.3

2.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.78

0.72

1.4

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

105

1.47

0.70

1.0

1.1

iu/ml

21.8

18.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.56

0.63

2.4

5.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

108

1.43

0.63

1.9

1.5

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.64

0.62

1.0

1.1

—

26.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

133

1.38

0.62

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

102

0.57

0.61

6.7

5.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.54

0.59

1.4

1.1

—

(40765096) Chromosome analysis panel by Banding

343

1.21

0.56

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

111

1.39

0.56

1.6

2.7

—

(4133840)

247

1.25

0.56

1.4

1.2

—

(3015183) Erythrocyte sedimentation rate

361

0.80

0.55

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

124

1076

1.11

0.54

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10796

103568

1.02

0.52

5.6

4.8

mmol/l

2.4

2.7

289.88

9706

93334

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.39

0.50

1.1

ug/l

86.0

81.2

—

(3008898) HLA-B27 [Presence]

250

2575

0.93

0.48

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

441

1.16

0.46

1.2

1.3

mmol/l

6.2

6.0

0.45

419

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3762

36762

0.98

0.44

4.6

5.2

ug/l

3.7

0.04

3261

32746

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

126

0.69

0.43

1.0

1.1

u/ml

51.8

60.3

—

120

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10530

101066

1.02

0.42

5.1

4.4

mmol/l

4.3

4.7

215.21

9507

91657

(3022475) Manganese [Moles/volume] in Blood

1.40

0.42

1.0

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

6.1

—

0.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.51

0.41

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

501

0.87

0.41

1.3

g/l

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

470

0.86

0.40

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.39

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.42

0.39

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

1.42

0.39

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.42

0.39

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.41

0.35

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

105

932

1.09

0.35

1.6

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

186

1689

1.06

0.34

2.0

1.8

pmol/l

176.8

203.0

2.54

169

1583

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

246

1.18

0.34

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

528

1.11

0.33

1.1

—

(3020650) Glucose [Presence] in Urine

256

1.17

0.32

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

214

1.17

0.29

5.8

6.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.29

0.29

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

383

0.88

0.28

1.1

u/ml

3.8

1.5

0.33

103

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

445

1.11

0.26

5.6

4.1

u/ml

43.3

48.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

329

0.88

0.25

1.1

u/ml

0.2

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

114

1168

0.94

0.25

1.1

u/ml

1.7

0.9

0.31

520

(40768793) Breast Pathology biopsy report

231

2319

0.96

0.24

1.4

1.3

—

(40762814) Titanium [Mass/volume] in Blood

237

1.14

0.23

2.0

2.2

ug/l

3.5

3.6

0.09

(3003888) Timothy IgE Ab [Units/volume] in Serum

119

1214

0.94

0.23

1.1

u/ml

2.0

4.2

2.07

619

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.34

0.23

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

387

0.90

0.23

1.1

u/ml

0.6

2.1

0.93

125

(46235168) Fasting glucose [Moles/volume] in Blood

120

1.21

0.23

1.9

mmol/l

7.7

7.4

—

(3035933) Granulocytes/100 leukocytes in Blood

220

1.14

0.22

6.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

207

2076

0.96

0.21

1.4

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1413

13436

1.02

0.21

1.5

1.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.26

0.20

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

211

0.87

0.20

1.2

1.1

u/ml

12.9

7.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

204

1.13

0.20

1.0

1.1

u/ml

0.6

5.8

0.63

107

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

204

1.13

0.20

2.6

1.4

ug/l

3.5

2.2

0.54

105

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.19

13.8

9.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

321

0.90

0.19

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

105

1.19

0.18

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2793

26720

1.01

0.17

1.8

1.6

mmol/l

1.5

1.3

9.67

2312

21834

(3025018) Bordetella pertussis Ab [Titer] in Serum

478

0.93

0.17

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

418

0.92

0.17

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.13

0.16

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.10

0.15

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

135

1343

0.97

0.12

1.1

u/ml

1.7

1.6

0.06

550

(3025577) Chromium [Mass/volume] in Blood

803

0.96

0.11

2.0

ug/l

1.9

2.4

1.18

674

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

428

0.95

0.10

1.1

u/ml

9.7

5.4

—

(42870560) Thyrotropin [Units/volume] in Cord blood

1.15

0.10

1.0

mu/l

18.1

7.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

130

1.11

0.10

1.3

1.2

mmol/l

5.5

6.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.14

0.09

1.4

1.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

242

2377

0.98

0.09

1.8

1.7

nmol/l

49.7

43.8

2.22

233

2283

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

527

1.04

0.09

1.1

iu/ml

9.8

11.0

0.14

112

(3003338) MCHC [Mass/volume]

8785

84567

1.00

0.08

46.3

18.5

g/l

331.6

331.8

1.15

8698

83750

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.78

0.08

1.4

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.04

0.07

2.0

2.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10393

100126

1.00

0.05

5.1

4.3

mmol/l

1.4

1.5

22.82

9322

90192

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

273

0.95

0.05

1.3

1.5

mmol/l

8.5

8.2

0.17

155

(3002523) Influenza virus A Ag [Presence] in Specimen

111

1057

1.01

0.03

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

103

0.94

0.01

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

111

1062

1.01

0.01

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

827

0.99

0.01

1.9

ug/l

3.6

3.8

0.09

729

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

252

0.99

0.00

3.6

1.8

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758358) Immune stain study

0.88

0.00

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.93

0.00

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

2.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FLUIDELECTRO and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_FLUIDELECTRO	2.069 [1.88, 2.28]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.075

During the follow-up period (1.1.1998 — 31.12.2019), 30904 out of 62802 females with E4_FLUIDELECTRO died.

Males

Parameter	HR [95% CI]	p-value
E4_FLUIDELECTRO	3.843 [3.36, 4.4]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 19521 out of 38323 males with E4_FLUIDELECTRO died.

Mortality risk

Mortality risk for people of age

years, who have E4_FLUIDELECTRO.

N-year risk	Females	Males
1	0.214%	0.689%
5	1.134%	4.028%
10	2.629%	9.432%
15	5.084%	16.832%
20	8.733%	27.242%

Relationships between endpoints

↥

Index endpoint: E4_FLUIDELECTRO – Other disorders of fluid, electrolyte and acid-base balance

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of fluid, electrolyte and acid-base balance

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints